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INTRODUCTION 
Acute pancreatitis is a common disorder with substantial burden on the 
healthcare system
1
. Acute pancreatitis includes wide spectrum of disease varying 
from mild self-limiting symptoms to fulminant multi organ failure and high 
mortality. The overall mortality rate is 3-10%, wherein 11-30% of cases are with 
severe disease manifested as pancreatic necrosis. 
`1n 1889, Reginald Fitz described the classic clinico-pathological features of 
acute pancreatitis and opined about the ineffectiveness and hazards of early 
operative intervention. 
The rationale behind the assessment of severity is mainly for practical 
purpose, where mild pancreatitis responds to supportive measures well but severe 
pancreatitis requires intensive monitoring of various parameters, specific 
therapeutic interventions and it has guarded prognosis. 
Since 1974, several scoring systems have been developed clinically and 
radiologically for this purpose, including Ranson’s criteria, the acute physiology 
and chronic health evaluation (APACHE II) score, Medical Research Council 
Sepsis Scoring (MRCS) and Bedside Index for Severity in Acute Pancreatitis 
(BISAP). 
Current methods of stratification of risk factors in acute pancreatitis have 
much important limitations. The Ranson’s and Modified Glasgow score (IMRIE’s) 
contains data which are not routinely collected during hospitalization. Both these 
study require 48 hrs. to complete, thereby minimizing the most precious early 
therapeutic window period. 
The most commonly used APACHE II scoring system however was 
originally formulated as an intensive care instrument, which required a large 
number of parameters to be collected, some of them may not be relevant to 
prognosis
1
. 
An ideal prognostic method should be able to differentiate between patients 
with mild & severe disease, easy to use, and widely available and should be 
accurate, and should have low interobserver variability. It should also be able to 
apply early in disease process so that patient who could prone to develop potential 
complications will be closely monitored and treated if possible empirically.  
 
 
 
REVIEW OF LITERATURE 
HISTORY OF THE PANCREAS 
The pancreas was generally ignored in antiquity, both as an organ and as a 
seat of disease. 
The pancreas was first discovered by Herophilus, a Greek anatomist cum 
surgeon, born in 336 BC on the Asiatic side of the Bosporus in Chalcedon
2
.  
The word pancreas first mentioned in the writings of Eristratos (310-250 
B.C.). The Four hundred years later, Rufus,(1st or 2nd Century AD), an anatomist 
cum surgeon of Ephesus, gave the name “pancreas”. Written in Greek language, 
the word meant “pan: all, kreas: flesh”2. 
Galen (Claudius Galenus 138-201 AD), “Physician to the Gladiators” of 
Rome& the Roman Emperor, taught that the pancreas serves as a cushion to 
protect the large blood vessels lying behind it
2
. 
In March 2, 1642, a German émigré, Johann Georg Wirsüng, discovered the 
pancreatic duct at San Francisco Monastery in Padua, Italy. But it was named by 
his colleague as “The Duct of Wirsüng”2.Whereas papilla, the enlargement of that 
duct at its junction with the common bile duct (CBD) which projects into the 
second part of duodenum, were first described by Vater in 1720. Santorini, in 
1734, described the accessory duct that bears his name.
 
In 1869, Paul Langerhans (“Junior”), a student of the famous Berlin Institute 
of Pathology, headed by the eminent Professor Rudolph Virchow, described the 
islets of the pancreas that was subsequently known as the “islets of Langerhans”, 
an endocrine system which lies within the pancreas
2
. This was the first good 
histologic description of the pancreas. 
In 1893, Laguesse suggested that the islet cells produce a hormone. In 1909 
Jean de Meyer suggested the name 'insulin' for this hormone. 
Eugene Lindsay Opie (1873-1971) was able to show the association between 
diabetes and failure of the islet cells and in 1901, proposed his "common channel" 
hypothesis
3
. 
In 1908, Julius Wohlgemuth, of Berlin, devised a method for measuring the 
concentration of serum amylase (“diastase”), which was found to be most useful 
for diagnosing the acute pancreatitis prior to laparotomy or autopsy
2
. 
Since 1898, many surgeons undertook various steps for the resection of 
tumors of ampulla and head of the pancreas. Allen O. Whipple (1881-1963), son of 
American missionaries in Persia, was recognized as the “Father of Pancreatic 
Surgery” for his successful single stage surgery in pancreatic head tumors2. 
In 1963, the first Marseilles Symposium favored the development of 
classification system for pancreatitis. This was revised in 1984; at the second 
Marseilles Symposium. 
Finally, at the Atlanta Symposium, in 1992, clinically oriented classification 
system was established for acute pancreatitis. 
In the upcoming years, we may expect further refinements in classification 
systems with the availability of MRI and other newer innovative technologies. 
Although the disease now classified as acute pancreatitis has been known 
from antiquity, not until the mid-19th century did the importance of pancreas and 
its severity became evident. In 1889, Fitz presented a succinct clinical and 
pathologic feature of acute pancreatitis. Moynihan in 1925 described "the most 
terrible of all the calamities which occur in relation with the abdominal viscera" as 
acute pancreatitis
4, 5
. 
 
 
 
Gross Anatomy 
The pancreas perhaps considered as the most unforgivable organ in the 
human body, which threatens most surgeons to even palpating it unnecessarily
6
. 
This is a retroperitoneal organ which lies obliquely from the C-loop of the 
duodenum to the hilum of spleen
7
. 
The pancreas lies posterior to the stomach, roughly in the Trans pyloric 
plane. The gland weighs approximately 80 g, varying from  
75 – 125g and measures 15 to 22 cm length in adults7. 
The pancreas has four parts
7, 8
: 
 The head (which includes the uncinate process),  
 The neck,  
 The body and 
 The tail. 
 
 
 
The head lies in the C- loop of the duodenum overlying the body of second 
lumbar vertebra and the inferior vena cava, with the aorta beneath the neck of the 
gland, more medially and lies posterior to transverse mesocolon. The right renal 
artery and both renal veins lie posterior to the head. Coming off the side of the 
pancreatic head and passing to the left and behind the superior mesenteric vein is 
the pancreatic uncinate process.  
The neck of pancreas lies directly anterior to the portal vein. Behind the 
neck of the pancreas, near its upper border, the superior mesenteric vein joins the 
splenic vein and continues toward the portahepatis as the portal vein. The inferior 
mesenteric vein often drains into the splenic vein near its confluence with portal 
vein. Sometimes, the inferior mesenteric vein drains into the superior mesenteric 
vein or merges with the superior mesenteric portal venous junction and forms a 
trifurcation. The common bile duct lies within a groove in head of the gland or 
embedded within it, until joining the main pancreatic duct at ampulla of Vater and 
opens into the 2
nd
 part of the duodenum. 
The body and tail of the pancreas related posteriorly to splenic artery and its 
vein. The splenic vein lies in a groove on the posterior surface of the pancreas and 
draining multiple fragile pancreatic venous branches. These vessels must be ligated 
to perform a spleen-sparing distal pancreatectomy. The splenic artery runs parallel 
and just superior to the vein along the postero superior edge of the body and tail of 
pancreas. The splenic artery often has tortuous course. The peritoneum covers the 
anterior surface of the pancreatic body. Once the gastrocolic omentum was 
divided, the body and tail of pancreas can be visualized along the floor of the lesser 
sac, just posterior to the stomach. Pancreatic pseudocysts commonly develop in 
this area, and the posterior aspect of the stomach can form the anterior wall of the 
pseudocyst, allowing drainage into the stomach. The transverse mesocolon base 
attaches to the inferior margin of the body and tail of pancreas. 
The body of pancreas overlies the aorta at origin of the superior mesenteric 
artery. The neck of the pancreas overlies the vertebral body of L1 and L2, and 
blunt antero-posterior trauma can compress the neck of the pancreas against the 
spine, causing parenchymal and ductal injury. The neck divides the pancreas into 
approximately two equal halves.  
The tail is referred to as the small portion of the pancreas that lies in front of 
the left kidney and was nested in the splenic hilum near the splenic flexure of 
colon. 
 
 
Pancreatic Ductal Anatomy: 
The common variations in pancreatic duct anatomy can be appreciated by 
understanding the embryology. The pancreas is formed by the fusion of a ventral 
and dorsal bud
9
.  
 The duct from the smaller ventral bud, which arises from the hepatic 
diverticulum, connects directly to the CBD.  
 The duct from larger dorsal bud, which arises from the duodenum, drains 
directly into the duodenum.  
The duct of the ventral anlage becomes the duct of Wirsung, and from the 
dorsal anlage becomes the duct of Santorini. The ducts from each anlage usually 
fuse together in the pancreatic head such that most of the pancreas drains through 
the Wirsung, or main pancreatic duct (MPD), into the common channel formed 
from the CBD and MPD. 
The length of common channel is often variable. In about one third of 
patients, the CBD and MPD remains distinct from the papilla; the two ducts may 
merge at the papilla in another third, and in the remaining third a true common 
channels will be there for few millimeters.  
Commonly, the duct from the dorsal anlage, the duct of Santorini, persist as 
the lesser pancreatic duct, and sometimes drains directly into the duodenum 
through the lesser papilla just proximal to the major papilla. In approximately 30% 
of patients, the duct of Santorini ends as a blind accessory duct and does not empty 
into the duodenum. In 10% of patients, the ducts of Wirsung and Santorini fail to 
fuse with each other. This ends up with the majority of drainage via the duct of 
Santorini and lesser papilla, while the inferior part of the pancreatic head and 
uncinate drains via the duct of  Wirsung and major papilla. This normal anatomic 
variant, which occurs in 10% of patients, is referred to as pancreas divisum. In a 
minority of these patients, the lesser papilla can’t be to handle the flow of 
pancreatic juices from the majority of the gland. This relative outflow obstruction 
can result in pancreatitis and is sometimes treated by sphincteroplasty of the minor 
papilla. 
.  
The MPD is normally 2 to 3 mm in diameter and lies between the superior 
and inferior borders and closer to the posterior surface. The MPD pressure inside is 
about twice that of in the CBD, thus said to prevent bile reflux into the pancreatic 
duct.  
 
 
The muscle fiber which lies around the ampulla forms the sphincter of Oddi 
that controls the flow of biliary and pancreatic secretions into the 2
nd
 part of 
duodenum. Contraction and relaxation of this sphincter is regulated by both 
hormonal and neural factors. When the accessory pancreatic duct or lesser duct 
drains into the duodenum, a lesser papilla can be identified 2 cm proximal to the 
major papilla. 
 
 
Arterial supply 
The pancreatic blood supply comes mainly from the celiac axis and the 
superior mesenteric artery
7, 8
. 
The coeliac axis gives the common hepatic artery which in turn gives rise to 
the gastroduodenal artery before continuing toward the porta hepatis as the hepatic 
artery proper. The gastroduodenal trunk becomes the superior pancreaticoduodenal 
artery as it passes behind the first portion of the duodenum and branches into the 
anterior and posterior divisions.  
 
 
The superior mesenteric artery while passing behind the neck of pancreas, it 
gives off the inferior pancreaticoduodenal artery, this quickly divides into the 
anterior and posterior divisions. The superior and inferior pancreaticoduodenal 
arteries anastomose within the parenchyma of the head of pancreas along the 
medial aspect of the C-loop of duodenum to form arcades that give off numerous 
branches to duodenum and head of pancreas. Therefore, it is impossible to resect 
the pancreatic head without devascularizing blood supply to the duodenum, unless 
a rim of pancreas containing the pancreaticoduodenal arcade is preserved.  
The body and tail are supplied by multiple branches from splenic artery. 
Three vessels run perpendicular to the long axis of the pancreatic body and tail and 
connect the splenic artery and inferior pancreatic artery. They are, from medial to 
lateral, the dorsal (AKA the transverse pancreatic artery), great, and caudal 
pancreatic arteries. These arteries form arcades within the body and tail of 
pancreas, and account for rich blood supply to the organ. 
Venous drainage 
 The venous drainage of the pancreas follows the arterial supply
7, 8
. The veins 
are usually superficial to the arteries within the parenchyma of the pancreas. There 
is an anterior and posterior venous arcade within the pancreatic head. The superior 
vein drains directly into the portal vein and the posterior inferior arcade drains 
directly into inferior mesenteric vein. The anterior inferior pancreaticoduodenal 
vein joins the right gastro-epiploic vein and the middle colic vein and forms a 
common venous trunk that drains into the (SMV) superior mesenteric vein. 
Traction on the transverse colon during colectomy can tear these fragile veins, 
which then retract into the parenchyma of the pancreas, making control tedious. 
There also are numerous small venous branches coming from the pancreatic 
parenchyma directly into the lateral and posterior aspect of the portal vein. Venous 
return from the body and tail of the pancreas drains into the splenic vein.  
 
 
Lymphatic drainage 
The pancreas has rich lymphatic drainage and follows venous drainage in all 
directions
7
. This diffuse lymphatic drainage contributes to the fact that pancreatic 
cancer often presents with positive lymph nodes and a high incidence of local 
recurrence after resection. Lymph nodes can be palpated along the posterior aspect 
of pancreatic head in the pancreaticoduodenal groove, where the mesenteric vein 
passes under the pancreatic neck, along inferior border of the pancreas, along the 
hepatic artery ascending into the portahepatis, and along the splenic artery and 
vein. The pancreatic lymphatics also communicate with lymph nodes in the 
transverse mesocolon and mesentery of the proximal jejunum. Tumors in the body 
and tail often metastasize to these nodes and lymph nodes along the splenic vein 
and in the hilum of the spleen.
 
 
Nerve supply 
The pancreas is innervated by both sympathetic via splanchnic nerve & 
parasympathetic via vagus nerve
7, 8
. The acinar cells responsible for exocrine 
secretion, the islet cells responsible for endocrine secretion, and the islet 
vasculature are innervated by both systems. The parasympathetic system stimulates 
endocrine and exocrine secretion and the sympathetic system inhibits secretion. 
The pancreas is also innervated by neurons that secrete amines and peptides, such 
as somatostatin, calcitonin gene-related peptide (CGRP), vasoactive intestinal 
peptide (VIP), and galanin. The exact physiological role of these neurons is not 
certain, may appear to affect both exocrine and endocrine function. The pancreas 
also has a rich supply of afferent sensory fibers, which are responsible for the 
intense pain associated with advanced pancreatic cancer, as well as acute and 
chronic pancreatitis. These somatic fibers travel superiorly to the celiac ganglia. 
Interruption of these somatic fibers can stop transmission of pain sensation in 
pancreatic disease. 
Histology 
Pancreas has exocrine and the endocrine glandular tissues. The exocrine 
pancreas consists of acinar glands whereas the endocrine part consists of islets of 
Langerhans
10
. 
The pancreas contains 85% exocrine gland, 10% extracellular matrix, and 
4% blood vessels & the major ducts, and only 2% of endocrine tissue
11
. Thus the 
endocrine and exocrine pancreas is thought to be functioning separately, but 
coordinated well for regulating the feedback system of digestive enzyme and 
hormone secretion. 
The acinar cells, so named because they are clustered like grapes on the stem 
of a vine, are organised into lobules. The main duct ramifies into intralobular and 
interlobular ducts, ductules and finally acini, that secretes into a centrally located 
acinar space that communicates with the main pancreatic duct. Histologically, 
acinar cells have a high content of endoplasmic reticulum and an abundance of 
apically located eosinophilic zymogen granules. The cells lining the main 
pancreatic duct are tall columnar cells, and many contain mucin granules. With 
progression from the large ducts to the smaller intralobular and interlobular ducts, 
the lining cells become flatter, assuming a cuboidal configuration, and mucin 
granules are no longer seen. Centroacinar cells, located at the junction between 
ducts and acini, resemble acinar cells in size and shape but lack zymogen 
granules
7
. 
 
 
  
 
 
 
 
 The islets of Langerhans are distributed throughout the pancreas. Within an 
islet, the B cells form an inner core surrounded by the other cells. Capillaries 
draining the islet cells drain into the portal vein forming a pancreatic portal system. 
Surgical physiology 
In response to a meal, the pancreas secretes digestive enzymes in an alkaline 
(pH 8.4) bicarbonate-rich fluid. The duodenal mucosa releases the hormone 
secretin which evokes a bicarbonate-rich fluid. Cholecystokinin-pancreozymin 
(CCK) is released from the duodenal mucosa in response to food: CCK produces 
no increase in the volume of secretion, but is responsible for enzyme secretion. 
Vagal stimulation increases volume. Approximately 6 - 20 g of digestive enzymes 
enters the duodenum each day
7, 8
.  
Exocrine Pancreas 
The pancreas secretes about 500 to 800 mL of colourless, odourless, 
isosmotic, alkaline, pancreatic juice daily
7
. Pancreatic juice is made up secretions 
from ductal and acinar cells. The acinar cells secrete the enzymes that are 
responsible for digestion of carbohydrate, protein, and fatty foods. 
Pancreatic amylase is the only enzyme secreted in active form and all other 
enzymes are secreted in proenzymes form which requires further activation for 
their action.Familial pancreatitis is a condition, where there is no expression of 
normal trypsinogen inhibitors, like SPINK1 or pancreatic secretory trypsin 
inhibitor (PSTI). Trypsinogen is expressed in several isoforms and a missense 
mutation on the cationic trypsinogen, or PRSS1, results in premature, 
intrapancreatic activation of trypsinogen
12
. This accounts for the basis of hereditary 
pancreatitis. 
 
  
 
 
 
 
 
 
 
At the time of secretion from the pancreatic acini, the proteolytic enzymes 
are in an inactive form, the maintenance of which is important in preventing 
pancreatitis.
 
Endocrine Pancreas 
There are about 1 million pancreatic islet cells present in adults normally. 
The size varies from 40 – 900 µm. largest cells lie close to major arterioles and 
smaller cells are embedded more deeply in the parenchyma. Most islets contain 
five major types of cells:  
1. α cells - secretes glucagon(20%)  
2. β cells - secretes insulin(75%)  
3. δ cells - secretes somatostatin  
4. ε cells - secretes ghrelin and 
5. PP cells - secretes pancreatic polypeptide. 
  
ACUTE PANCREATITIS 
Definition: 
Acute pancreatitis is “an inflammatory disease, associated with little or no 
fibrosis of the pancreas”. There are several initiating factors, which include 
gallstones, alcohol, trauma, and infections, and, rarely hereditary
7
.  
Etiology of acute pancreatitis: 
There are so many different factors have been implicated in the causation of 
this disease. On the basis of worldwide data, the most common cause are 
gallstones, account for about 45 percent of cases. Alcoholism is the second 
common cause, in about 35 percent of cases. In a study done in New Delhi, India, 
gall stones and alcoholism were found to be the cause in 49% and 23.6% cases, 
respectively
13
. 
The disease occurs at higher rate in young men and older women. Females 
are more prone to have gall stone pancreatitis and males are more prone to have 
alcohol induced pancreatitis
14
. 
CAUSES OF ACUTE PANCREATITIS
7
:
 
Alcohol 
Biliary tract disease 
Obstructive causes: 
 Choledocholithiasis 
 Ampullary carcinoma or pancreatic malignancy 
 Papillary obstruction by worms/foreign bodies   
 Pancreas divisum with minor duct obstruction 
 Choledochocele 
 Duodenal diverticula at periampullary region 
 Spasm sphincter of Oddi 
Toxins or drugs:  
 Toxins:- ethanol/methanol, scorpion sting, organo phosphorous compounds 
 Drugs:- Definite Cause 
 5-Aminosalicylate (ASA) 
 6-Mercaptopurine (6-MP) 
 Azathioprine  
 Cytosine arabinoside (cytarabine) 
 Didanosine 
 Diuretic agents 
 Estrogens, etc. 
 
Probable Cause 
 Acetaminophen 
 α-Methyl-DOPA 
 L-Asparaginase 
 Isoniazid (INH) 
 Phenformin, etc. 
Trauma: 
 External / surgical traumatic injury to the abdomen. 
 Iatrogenic injury- postoperative trauma, post ERCP, post endoscopic 
sphincterotomy and manometry of sphincter of Oddi 
Metabolic abnormalities: 
 Hypercalcemia 
 Hypertriglyceridemia 
Inherited conditions 
Infection: 
 Parasitic:- ascariasis, Clonorchis sinensis 
 Viral:- mumps, rubella, hepatitis A, B, non-A, non-B, coxsackie B, echo 
virus, adenovirus, CMV, varicella, EBV, HIV. 
 Bacterial: - mycoplasma pneumoniae, Campylobacter jejuni, Myco. 
tuberculosis, MAC, legionella pnemophila, leptospiral infection 
Vascular causes: 
 hypo perfusion causing ischemia (e.g., after major cardiac vascular surgery) 
 Athero-embolism 
 Vasculitis-SLE, PAN, malignant hypertension 
Miscellaneous causes: 
 Peptic ulcer penetration 
 Cystic fibrosis 
 Crohn’s disease 
 Reye’s syndrome 
 Hypothermia 
Idiopathic causes 
Gall stones 
Gall stones are the leading cause of acute pancreatitis in most series (30-
60%). Women are more commonly affected than men, and the peak incidence is 
between 50 to 60 yrs of age
14
.
 
In 1901, Opie, at the Johns Hopkins Hospital in Baltimore, documented 
impaction of gallstone in the ampulla of Vater during the autopsy of a patient 
(operated on by Halsted) who had died due to gallstone pancreatitis and thereby 
first to describe the pathogenic mechanism of gallstone induced pancreatitis
3
.He 
suggested that the stone might have caused outflow obstruction from a common 
‘biliopancreatic channel’. This led him to propose the "common-channel 
hypothesis
3
" in which a blockage below the junction of the biliary and pancreatic 
ducts would cause bile to flow into the pancreas, which could then be damaged by 
the detergent action of bile salts. Although this bile reflux theory was originally 
favored, most observers now believe that it is stone-induced pancreatic duct 
obstruction and ductal hypertension, rather than bile reflux that triggers acute 
pancreatitis. 
Opie’s hypothesis regarding the pathogenesis of pancreatitis has dominated 
much of the twentieth century, but it’s regarded as a myth today. By experiments 
in opossum animal model with easily accessible long common channel, Lerch et al. 
have demonstrated that pancreatic duct obstruction alone causes necrotizing 
pancreatitis which can’t be distinguishable from that occurred when CBD also 
occluded simultaneously. On commenting the demise of the Opie’s theory, 
Fitzgerald remarked, ‘never in medical history have so many owed so much to a 
single stone’.  
Another proposed mechanism of causation postulates that passage of a 
gallstone through the sphincter of Oddi renders it momentarily incompetent, 
permitting the reflux of duodenal juice containing activated digestive enzymes into 
the pancreatic ductal system. 
 
 
 
 
 
 
 
 Microlithiasis (occult gall stones/biliary sludge) is a well-known cause of 
acute pancreatitis. The diagnosis of microlithiasis should be ruled out before 
labeling the disease as idiopathic pancreatitis. Biliary microscopy & 
endosonogaraphy are recommended nowadays to diagnose the microlithiasis. 
 
Alcohol 
The second most common etiological agent, alcohol is responsible for about 
30% of all cases. In a patient with history of exposure to alcohol with absence of 
other possible causes, even the first attack of pancreatitis is considered to be 
related to alcoholic pancreatitis. However, it is possible that a first attack of 
alcohol-related pancreatitis in the typical longstanding alcohol user is really the 
first manifestation of chronic pancreatitis. The disease can recur with continuous 
abuse of alcoholism. The nature of alcohol that was consumed (i.e., beer, wine, or 
hard liquor) is less significant than a daily intake of between 100 and 150 g of 
ethanol
7
.
 
Various theories have been put forward
7, 8
: 
1. Alcohol consumption can alter lipid metabolism, and a transient 
hyperlipidemic state that causes hypertriglyceridemia and the generation of 
fatty acids as well as their ethyl ester metabolites, that can injure the 
pancreas. 
2. Alcohol consumption causes intra pancreatic generation of oxygen free 
radicals, which can injure the pancreas. 
3. It promotes secretion of pancreatic juice that is high in proteolytic enzyme 
content but low in enzyme inhibitor content. Enzyme activation can 
theoretically occur in these conditions and cause pancreatic injury. 
4. The "secretion with blockage" mechanism is possible because ethanol 
causes spasm of the sphincter of Oddi, leading to ductal hypertension and, 
more important, ethanol is a metabolic toxin to pancreatic acinar cells, where 
it can interfere with enzyme synthesis and secretion. 
5. Secretion of enzyme-rich fluid, deficient in enzyme inhibitors could also 
lead to precipitation of protein and calcium within this protein matrix, 
causing multiple ductal obstructions, while continued secretion can cause 
pressure to buildup and the formation of intra-ductal plugs, which cause 
ductal obstruction and ductal hypertension. 
6. Ethanol causes focal ischemic injury to the gland, thereby transiently 
decreases pancreatic blood flow. 
Hyperlipidemia 
It is responsible in 1.5-4 % of cases. Triglyceride level > 1000 mg/dl 
increases the likelihood of developing pancreatitis. It is hyperlipidemia type I, IV 
or V that causes pancreatitis. It has been suggested that lipase can liberate large 
amounts of toxic fatty acids into the pancreatic microcirculation
8
. This could lead 
to endothelial injury, sludging of blood cells, and consequent ischemic states. 
 
Hypercalcemia 
Hypercalcemia secondary to hyperparathyroidism or any other cause can 
cause acute pancreatitis. The mechanism most likely involves hyper secretion and 
the formation of calcified stones intra ductally. 
Iatrogenic Pancreatitis 
Acute pancreatitis can be associated with a number of surgical procedures
7
, 
most commonly those performed on or close to the pancreas, such as pancreatic 
biopsy, biliary duct exploration, distal gastrectomy and splenectomy. Acute 
pancreatitis is associated postoperatively with Bill Roth II gastrectomy and 
jejunostomy, in which increased intraduodenal pressure can cause backflow of 
activated enzymes into the pancreas. However, pancreatitis also can occur in 
association with surgery that uses low systemic perfusion, such as 
cardiopulmonary bypass and cardiac transplantation. Acute pancreatitis has been 
reported to be associated with severe hypothermia, and the hypothermia associated 
with cardiopulmonary bypass may be similarly causative. It also is possible that 
atheromatous emboli or ischemia may cause pancreatic injury. Most commonly, 
endoscopic retrograde cholangio pancreatography (ERCP) results in pancreatitis in 
2 to 10% of patients, due to direct injury and/or intraductal hypertension. Similarly 
manometry of sphincter of Oddi is associated with increased risk for AP. 
  
Tumours 
About 1 to 2% of patients with acute pancreatitis may have pancreatic 
malignancy, in which an episode of acute pancreatitis could be the first clinical 
sign of a periampullary tumor. In both conditions, the pancreatitis occurs probably 
due to blockade of pancreatic secretion and its upcoming consequences. 
Drugs 
For practical reasons, it often is difficult to implicate a drug as the cause of 
pancreatitis. Many drugs can produce hyperamylasemia and/or abdominal pain, 
and a drug is considered to be a cause if the pancreatitis-like illness resolves with 
its discontinuation. 
Infections 
Though mumps, coxsackievirus, and Mycoplasma pneumoniae are believed 
to be capable of inducing acute pancreatitis by infecting the acinar cells, none of 
these agents has been isolated from a diseased pancreas. The antibody titres to 
mumps and coxsackievirus are elevated in about 30% of cases with acute 
pancreatitis with no other identified cause. However, this elevation may be an 
anamnestic or nonspecific response to pancreatitis. 
  
Miscellaneous Causes 
The infestations by Ascaris lumbricoides and the liver fluke Clonorchis 
sinensis, which is endemic to China, Japan, and Southeast Asia, cause Oriental 
cholangitis, which is associated with cholangiocarcinoma obstructing the 
pancreatic duct.  
A dominant gene mutation following Mendelian inheritance is known to 
result in hereditary pancreatitis. Whitcomb and associates described several 
families from various parts of the world were found to have mutations in the 
cationic trypsinogen gene PRSS1, which results in acute pancreatitis.  
20 to 45% of patients with pancreas divisum (unfused ducts of Wirsung and 
Santorini) develop pancreatitis, but the failure of procedures to improve drainage 
of the lesser papilla in reducing attacks of pancreatitis, as well as the observed lack 
of ductal dilatation in such patients, contradicts pancreas divisum as an etiologic 
factor, rendering the role of this condition as yet unclear
12
.  
Other implicated factors include azotaemia, vasculitis, and the sting of the 
Trinidadian scorpion Tityus trinitatis. This scorpion's venom has been shown to 
cause neurotransmitter discharge from cholinergic nerve terminals, leading to 
massive production of pancreatic juice. Poisoning with anti-acetyl cholinesterase 
insecticides has a similar effect.  
Finally, no apparent cause can be ascribed to some episodes of acute 
pancreatitis, and these constitute the group referred to as idiopathic pancreatitis, 
which is the third most common cause of acute pancreatitis
15
. 
Pathophysiology 
Acute pancreatitis occurs in varying degrees of severity, the determinants of 
which are multifactorial. It is generally believed that acute pancreatitis is triggered 
by digestive enzymes which got activated inside acinar cells. This was thought to 
be counter acted by endogenously secreted pancreatic enzyme inhibitor. The 
ultimate severity depends upon the event that subsequently occurs following the 
acinar cell injury. The events are activation and recruitment of inflammatory cell, 
synthesis and release of cytokines and other chemical mediators of inflammation. 
Large amounts of liberated digestive enzymes however overwhelm the system as a 
whole. 
There are three reasons for this theory
7, 15
:  
(a)   The pancreas is digestible by the activated enzymes of the duodenum. 
(b)  Activated digestive enzymes are found within the pancreas during 
pancreatitis. 
(c)   The histology of pancreatitis is suggestive of a coagulative necrosis.  
However, the mechanism(s) of erroneous activation are not fully understood. 
 According to “colocalization hypothesis” digestive enzymes are localized in 
cytoplasmic vacuoles which also contain the lysosomal hydrolase Cathepsin B, 
which is known to activate trypsinogen
7
. Recent studies suggest that cathepsin B 
activity inhibition by highly specific inhibitor, CA-074me, protects against intra-
acinar cell activation of trypsinogen and hence pancreatitis. These findings suggest 
that the trypsinogen is activated because it erroneously colocalises in cytoplasmic 
vacuoles with cathepsin B. 
 
 
 
 
 
 
Recent studies suggest that trypsin, once activated inside the colocalized vacuoles    
(appears   similar   to   autophagic   vacuoles), mediates  the 
permeability of these organelles and release of their contents into the cytosol.  
Cathepsin  B  is  one of  the  enzymes  released  into the cytosol 
 
  
 
 
 
 
 
 
 
 
 
 
during pancreatitis. Once inside the cytosol, it initiates apoptotic cell death by 
permeabilizing mitochondrial membranes, which allows cytochrome C to be 
released into the cytosol. This initiates the apoptotic cascade and ultimately the 
apoptotic death of the acinar cells. 
FACTORS DETERMINING THE SEVERITY OF PANCREATITIS: 
The severity of acute pancreatitis varies significantly. Some may have mild 
form of the disease that is self-limiting, while others suffer a more severe and 
sometimes lethal attack. The factors determining the severity of pancreatitis are 
multifactorial, but their identification is of considerable therapeutic importance, 
because their manipulation may decrease the morbidity and mortality associated 
with the disease.  
In addition to the cells of the immune system like neutrophils, the pancreatic 
acinar cells are also a source of inflammatory mediators during pancreatitis. The 
list of factors associated with pancreatitis and associated lung injury include: tumor 
necrosis factor alpha, monocyte chemotactic protein-1, Mob1, interleukin-1β (IL-
1β), platelet activating factor, substance P, adhesion molecules [intercellular 
adhesion molecule-1 (ICAM-1) and selectins], IL-6, 8, 10, C5a, the CCR1 receptor 
and its ligands, granulocyte-macrophage colony-stimulating factor(GMCSF), 
macrophage migration inhibitory factor, COX-2, prostaglandin E1, nitric oxide 
(NO) and reactive oxygen species. The heat shock proteins are found to be 
protective in pancreatitis. The ultimate severity of pancreatitis and associated lung 
injury depends on the balance between the pro-inflammatory and anti-
inflammatory factors
7
.  
Several therapeutic regimens aimed at reducing the inflammatory response 
have been tested and include anti–tumor necrosis factor alpha antibody, IL-1 
receptor antagonist, IL-10, anti-ICAM-1 and anti-CD3 Ab, rPAF acetyl hydrolase, 
and the calcineurin antagonist FK506
8
.  
Recent studies also indicate that Toll-like receptor 4 (TLR4) is significant in 
determining the severity of acute pancreatitis. The TLR4 initiates a complex 
signaling pathway when it interacts with lipopolysaccharides that result in a 
proinflammatory response. Mice in which TLR4 is genetically deleted have 
significantly reduced pancreatitis; this suggests that TLR4 is a significant promoter 
of proinflammation. However, this effect appears independently of 
lipopolysaccharides and is probably mediated by a hitherto unknown TLR4 
agonist. It is likely that TLR4 antagonists would be a good therapy against 
pancreatitis
15
. 
An alternate approach to prevent or reduce the severity of pancreatitis is to 
inhibit intrapancreatic trypsinogen and NF-κB activation, the two events which 
occurs early in pancreatitis. Agents that specifically prevent an increase in trypsin 
activity, either by inhibiting trypsinogen activation and colocalization (e.g., low 
doses of wortmannin, water immersion, and thermal stress) or inhibiting the 
cathepsin B activity (E64d or CA074me), are found to be successful in reducing 
the severity in experimental rodent models. Prior thermal (and arsenite) & water 
immersion stress, up regulates hsp 70 and 60, respectively, not only prevent 
cerulein-induced trypsinogen activation, but also inhibit cerulein-induced NF-κB 
activation within the pancreas, hence protective in pancreatitis
7, 8
. 
 
 
 
Initiation of injury 
Block in pancreatic enzyme secretion 
Co-localization of zymogen granules and lysosomal enzymes 
Activation of trypsinogen & release of trypsin 
Activation of other zymogens 
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Ischemia            Multi organ failure 
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Schematic representation of the mechanisms of pathogenesis of  
acute pancreatitis
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Clinical presentation: 
The clinical presentation, diagnosis, and management of an acute attack of 
pancreatitis are similar regardless of whether that attack is acute or chronic 
pancreatitis. The acute pancreatitis can mimic like acute abdomen and should 
never be excluded in differential diagnosis
8
. 
Abdominal pain, nausea, and vomiting are the predominant symptoms. Each 
episode begins with severe pain, following a substantial amount of meal. The 
cardinal symptom is usually epigastric pain, but can occur anywhere in the 
abdomen or lower chest. The pain was described as "knifing" or "boring through" 
to the back, and might be relieved by leaning forward(Mohmadian prayer 
position). Pain starts 12-48 hours after a bout of alcohol or after a large meal in 
case of gall stone pancreatitis. Pain became generalized once peritonitis has been 
sets in
8, 15
. 
Peritoneal dialysis, post-operative situations, legionnaire’s disease are well 
known for the occurrence of uncommon painless pancreatitis. 
If patient develops generalized paralytic ileus abdominal distension and 
vomiting can occur. The vomiting may lead to gastro esophageal tears (i.e., 
Mallory-Weiss syndrome) and upper gastrointestinal bleeding. Vomiting is more 
intense in necrotizing pancreatitis than in edematous pancreatitis. Although 
vomiting and retching may be relieved by passage of a nasogastric tube, the pain 
usually persists even after gastric decompression. 
Fever is an important sign. Fever in the first week is due to acute 
inflammation mediated by cytokines. Fever in the second or third week is due to 
infected pancreatic necrosis. Fever in gall-stone induced pancreatitis, may be due 
to cholangitis and mandates prompt biliary decompression. 
Physical Findings: 
On examination, the patient may be tachypneic, hypotensive, and hyper 
thermic, and have tachycardia
7, 8
. The temperature was mildly elevated in 
uncomplicated pancreatitis. Voluntary and involuntary guarding may present over 
the epigastric region. The bowel sounds may be decreased or absent. There is 
usually no palpable swelling or masses. The abdomen may be distended with free 
intraperitoneal fluid, may associated with pleural effusion, particularly on the left 
side. 
With increasing severity, there are sequestrations of fluid in the retro 
peritoneum that leads to life threatening intravascular fluid loss. This leads to 
hemoconcentration. There might be bleeding into the retro peritoneum or 
peritoneal cavity which may dissect via the soft tissues and appears as a bluish 
discoloration around the umbilicus (Cullen's sign) or in the flanks (Grey Turner's 
sign) and the inguinal region (Fox's sign)
 17
. Neither sign is pathognomonic of AP; 
actually the Cullen’s sign was first described with ruptured ectopic gestation. 
 The severe intravascular fluid loss may lead to acute renal shutdown with 
elevated BUN and creatinine levels. And also there may be hyperglycemia, 
hypoalbuminemia, and hypocalcemia that are sufficient enough to produce tetany 
in few cases. 
Diagnosis: 
The clinical diagnosis is one of exclusion and diagnosis may be difficult 
despite the plenty of investigation that are available. 
Serum pancreatic enzymes: 
Serum pancreatic enzyme estimation is the gold standard for diagnosis
18
. 
The reason is pancreatic acinar cells synthesize, store, and secrete a large amount 
of digestive enzymes (e.g., amylase, lipase, trypsinogen, and elastase), the levels of 
which are elevated in the serum of most patients.
 
Amylase, lipase, elastase and trypsin were released into the blood stream at 
the same time, but their clearance varied with different sensitivities, depends on the 
timing of blood sampling after the onset of disease. 
Because of the ease of measurement, serum amylase levels are measured 
most often. Serum amylase concentration will increase immediately reaches the 
peak value within several hours after the onset of disease and remains elevated for 
3 to 5 days before returns back to normal. There was no significant correlation 
between the magnitude of serum amylase rise and severity of pancreatitis. But, 
there are many nonpancreatic causes of hyperamylasemia (e.g., biliary tract 
disease, intestinal obstruction, mesenteric ischaemia, acute appendicitis, mumps, 
parotitis, impaired amylase excretion etc.), that make the interpretation of this 
marker difficult
18
. In contrast, a patient with acute pancreatitis may have a normal 
serum amylase level, which could be due to several reasons like patients with 
hyperlipidemia; values might appear to be normal because of interference by lipids 
with chemical determination of serum amylase. The urinary amylase clearance 
from the circulation increases during pancreatitis; therefore, the urinary amylase 
levels might be more sensitive than serum levels. For these reasons, it is 
recommended to measure the urinary amylase concentrations, which usually 
remain elevated for several days after serum amylase levels have returned back to 
normal. In patients with severe pancreatitis associated with significant necrotic 
damage, the pancreas may not release large amounts of enzymes into the 
circulation. It is important to recognize that, in patients with severe pancreatitis, 
frequent measurement of serum enzymes is not needed. Patients with alcoholic 
pancreatitis, in general, have a smaller increase in serum amylase levels. Because 
hyperamylasemia can be observed in many extra pancreatic diseases, measuring 
pancreatic-specific amylase (p-amylase) rather than total amylase, which  
also includes salivary amylase, makes the diagnosis more specific  
(88 to 93%). 
The serum lipase estimation has been found to have high sensitivity and 
specificity in the diagnosis as there are no other sources of lipase
15, 17
. Total 
amylase is having a sensitivity of 84%, the serum P- amylase has 95% and lipase 
has 93%. Specificities for amylase, P-amylase and lipase respectively are- 88%, 
93% and 96%, respectively. Thus P-amylase is the enzyme with the higher 
diagnostic value. 
The rise of lipase: amylase has been found to differentiate alcoholic from 
nonalcoholic pancreatitis. The serum (SGPT) alanine aminotransferase level rise of 
three or more times above the base-line value has great specificity in diagnosing 
gallstonepancreatitis.
 
Immunologic assay like serum trypsinogen or immune lipase are generally 
less specific than the lipase assay. The increased urinary level of activation 
peptides released during either trypsinogen, procarboxypeptidase, or 
prophospholipase activation, may aid in predicting the severity of an attack.  
Leucocyte migration and activation has considered as major determining 
factor of local & systemic complications
8, 15
.  
Although methemalbumin levels sometimes rise during attacks of severe 
pancreatitis, and methemalbuminemia is indicative of a poor prognosis, 
methemalbumin levels are usually not measured. Circulating levels of several 
inflammatory mediators and acute phase reactants  
(e.g., IL-1, 6, TNF-alpha, and CRP) also increase during pancreatitis, and the 
magnitude of those increases can be used to predict the severity of an attack. C 
reactive protein is readily available in all centers and vales > 120mg/L, after 72 
hours are closely related to necrotising pancreatitis. 
  
Imaging: 
In general, the plain chest and abdominal radiographs can be useful in the 
management by identifying other causes for the patient's symptoms (e.g., 
pneumonia, perforated hollow viscous, mechanical bowel obstruction). Plain 
abdominal X-ray findings are either generalized or local ileus (known as sentinel 
loop), colon “cut-off” sign or “renal halo” sign. A chest radiograph may show left 
pleural effusion, elevated left hemi diaphragm or basal atelectasis
17
. 
Ultrasonography: 
Abdominal ultrasound (US) examination is the gold standard for 
confirmation of gallstones pancreatitis. It also helpful to detect extra pancreatic 
ductal dilations & pancreatic edema, swelling, free peritoneal fluid and 
peripancreatic acute fluid collections (PFCs).It may not be sensitive in about 20% 
of cases, due to bowel gas interference with the imaging.
 
CT scan: 
The contrast-enhanced computed tomography (CECT), has become gold 
standard for
17 
 Diagnosis 
 Assessing the severity 
 Detection of complications of acute pancreatitis. 
The Balthazar scoring system and other similar grading systems have 
incorporated various CT findings such as inflammation and fluid collections in & 
around the pancreas to correlate radiographic appearance with morbidity and 
mortality
19
.  
Early CT scans often fail to detect evolving necrosis, which become well 
demarcated by 2 to 3 days after the onset of symptoms. The CT scans are not 
useful in diagnosing necrosis or predicting the severity within the 24 hours of onset 
of illness. The sensitivity for identifying pancreatic necrosis using contrast-
enhanced CT scan approaches 100%, 4 days from diagnosis. CT scans also been 
useful in the early diagnosis of infected pancreatic necrosis and image guided 
aspiration of necrosis, when patient not improving clinically or who experience 
clinical decline. In the patient with moderate renal impairment or allergy to 
intravenous contrast material, magnetic resonance imagining (MRI) may be useful. 
MRI has been found to have sensitivity and specificity similar to contrast-enhanced 
CT for detecting severe acute pancreatitis. 
ERCP should be done in patients with acute pancreatitis , whose clinical 
course fails to improve despite full intensive care support, and in whom ampullary 
or common bile duct stone impaction is suspected, based on ultrasonography, or 
clinical/biochemical signs of cholangitis. It may also be helpful in patients with 
recurrent attacks of acute pancreatitis, without any obvious cause. It is useful in 
correcting potentially correctable lesions such as CBD stones with impaction, 
pancreas divisum, ampullary stenosis, pancreatic duct stenosis etc. 
Mild acute pancreatitis (MAP) Vs. Severe acute pancreatitis (SAP): 
Characteristic MAP SAP 
Process Mild, self-limiting Fatal attack or failure to settle on 
supportive therapy 
Course Resolves rapidly Emergence of local and systemic 
complications 
Hallmarks Edematous, 
interstitial 
inflammation of the 
pancreas 
Extensive and prolonged, pancreatic and 
retroperitoneal inflammation with 
superimposed patchy or generalized areas 
of necrosis and hemorrhage in the 
pancreas and surrounding tissues  
Fatality rate Does not exceed 
3% 
Fatality rate between 10-20% 
CECT Normal in 15-30% 
of patients 
May show pancreatic abscess, intra-
abdominal fluid collection 
 
Assessment of Severity: 
An early interpretation between mild and severe necrotizing pancreatitis is 
the most important thing for providing optimal care to the patient
7
. There are so 
many predictors available for assessing the severity, which includes early 
prognostication signs, serum markers, and CT scan
15
. 
Scoring systems in acute pancreatitis: The various prognostic scoring systems 
for assessing the severity will be discussed in detail later. 
UK guidelines for the management of AP
20
: 
 The correct diagnosis has to be made within 48 hrs. of admission. 
 The etiology has to be determined in 80% of cases at least and idiopathic 
cause should not exceed 20%. 
 The serum lipase assay has been preferred over serum amylase assay for 
diagnosis the acute pancreatitis. 
 The contrast enhanced computed tomography has to be preferred over USG 
for detection of the presence/absence of pancreatitis. 
Treatment:  
There are two phases in evolution of an acute attack of pancreatitis. Both 
phases are overlapping on each other
15, 17
.  
The initial phase, which lasts for 1 to 2 weeks, involves an acute 
inflammatory and autodigestive process that takes place within and around the 
pancreas. It may have systemic effects as well.  
The second phase, that may last for weeks or months, is primarily 
characterized by the development of local complications that are, themselves, the 
results of necrosis, infection and pancreatic duct rupture.
 
The initial management of patients with pancreatitis focuses on early 
establishment the diagnosis, assessing the severity, treating the major symptoms, 
and haltering the disease progression. The treatment for acute pancreatitis is 
largely supportive. Since 15-30 % patients develop severe pancreatitis, so each and 
every patient should be treated aggressively. The main aim of the treatment is 
‘allowing rest to the gland’ by oral feed and fluids restriction21. The goal of initial 
management consists of adequate fluid replacement, correction of electrolyte 
imbalance, nutritional support and prevention of local & systemic complications. 
Management of Pain 
Good analgesics should be given to these patients as the pain can be very 
severe in intensity. Most patients require narcotic analgesics. Meperidine is 
preferred as morphine induces spasm of the sphincter of Oddi, which can, at least 
theoretically, worsen biliary pancreatitis. 
Fluid and Electrolyte Management 
Aggressive fluid resuscitation is important to replenish extravascular, or 
"third space," fluid losses, which may be considerable. The fluid resuscitation is of 
utmost importance to prevent systemic complications, mainly acute renal 
insufficiency, that may occur with hypovolemia. Transudation of the fluid from 
intravascular space into the areas of inflammation (i.e., peripancreatic, 
retroperitoneum and into the pulmonary parenchyma and soft tissues elsewhere in 
the body) is the principle cause of hypovolemia. Furthermore, studies have shown 
that inadequate resuscitation may add upon as a significant risk that leads to further 
pancreatic injury.  
Banks and colleagues have showed that while aggressive fluid resuscitation 
might not prevent the progression to develop pancreatic necrosis. The degree and 
intensity of monitoring depends upon the disease severity
22
.  
During the first several days of a severe attack, circulating levels of many 
proinflammatory factors, including cytokines and chemokines, are elevated. This 
so-called “cytokine storm”, in many cases, triggers the systemic immune response 
syndrome, and as a result, the hemodynamic parameters of these patients may 
resemble those of sepsis associated with other disease states
23
. Heart rate, cardiac 
output, and cardiac index usually rise, and total peripheral resistance falls. 
Hypoxemia can also occur as a result of the combined effects of increased 
intrapulmonary shunting and a pancreatitis-associated lung injury that closely 
resembles that seen in other forms of ARDS. Fluid management, though critical, 
may be difficult when hypovolemia is combined with respiratory failure of ARDS.  
Measurement of central filling pressures, using a Swan-Ganz or central 
venous pressure catheter, can be helpful in guiding fluid management, particularly 
when hypovolemia is combined with lung injury. 
Nasogastric Decompression 
The nausea and vomiting of pancreatitis can result in significant fluid as well 
as electrolyte losses and retching can lead to gastro-esophageal mucosal tears and 
result in upper gastrointestinal bleeding (i.e., the Mallory-Weiss syndrome). For 
symptomatic relief and to increase patient comfort, nasogastric decompression may 
be needed, although the institution of nasogastric drainage does not shown to alter 
the eventual outcome of an attack
7, 8
. 
Prophylactic Antibiotics 
Infection is a serious complication of acute pancreatitis and is the most 
common cause of death
17
. It is mostly caused by the enteric bacteria and was seen 
commonly in necrotizing pancreatitis. Local infection were common with larger 
amounts of pancreatic necrosis, and this increases in incidence as time progresses 
for at least the first 3 weeks in the course of the disease. Aerobic and anaerobic 
gastrointestinal floras are the primary organisms involved, and infections may be 
either mono or polymicrobial in nature. The predominant microbes seen were E. 
coli (35%), Kleb. pneumoniae (25%), Streptococcus (25%), Staphylococcus 
(15%), and Pseudomonas (10%).The association of high mortality with pancreatic 
infection has been the rationale behind the use of prophylactic antibiotics widely in 
patients with pancreatic necrosis. In severe pancreatitis, beneficial effects have 
been observed with regimens that included imipenem alone, imipenem with 
cilastatin, metronidazole and third-generation cephalosporin (cefuroxime). Because 
Candida species are common inhabitants of the upper GI tract, Candida sepsis and 
secondary fungal infection of pancreatic necrosis is a risk in severe disease, and 
many surgeons advocate empirical therapy with fluconazole in severe acute 
pancreatitis. 
The duration of treatment has not defined clearly. A treatment course of 
1week to 4 weeks has been recommended commonly, but many of them limit the 
treatment to 2 weeks
17
. 
According to the current UK guidelines (Johnson 2005), the duration of 
antibiotic prophylaxis is 1 to 2 weeks
20
. 
Nutritional Support 
Classically speaking, the enteral feeding should be limited, thereby 
pancreatic stimulation and further pancreatic injury by the release of proteolytic 
enzymes can be avoided. Recent data, suggests that such strict limitations of 
enteral nutrition may have been unnecessary. Most of the severe acute pancreatitis 
patients found to have prolonged course of illness with hyper catabolic state and 
ileus that have led to a generous use of parenteral nutrition in them. 
The points favoring enteral nutrition are
7, 15
:  
 It might feasible, safe, and desirable in severe pancreatitis.  
 It has the advantage of avoiding the high cost of total parenteral nutrition 
(TPN) as well as its associated catheter-related complications. 
 The use of enteral nutrition may support intestinal mucosal integrity by 
avoiding the alteration in intestinal permeability & barrier function as seen 
with use of TPN. 
 
Treatments of Limited or Unproven Value 
In patients who develop severe disease, other treatment modalities may be 
tried.  The antiproteases like gabexate/aprotinin, antisecretory agents like 
octreotide and anti-inflammatory drugs or PAF antagonists like lexipafant were 
found to be less useful
15, 17
.  
Treatment of Early Systemic Complications of Pancreatitis 
The pathogenesis and management of the cardiovascular collapse, 
respiratory failure, renal failure, metabolic encephalopathy, gastrointestinal 
bleeding, and disseminated intravascular coagulation that complicate severe 
pancreatitis appear to be identical to those involved when these processes are 
superimposed on other disease states that are characterized by peritonitis and 
hypovolemia
8
.  
Cardiovascular collapse is largely caused by hypovolemia, and its 
management requires aggressive fluid and electrolyte repletion.  
The pulmonary manifestations of pancreatitis include atelectasis and acute 
lung injury. The latter appears to be similar to the acute lung injury caused by other 
systemic processes, including septic shock, ischemia and reperfusion, and massive 
blood transfusion. Management includes good pulmonary toilet combined with 
close monitoring of pulmonary function. For many patients, intubation and 
respiratory support may be required.  
Renal failure in pancreatitis is usually prerenal and is associated with a poor 
prognosis. In severe cases, dialysis, usually hemodialysis, may be required. 
Stress-induced gastro duodenal erosions account for most of the 
gastrointestinal bleeding, prophylaxis with antacids, H2-receptor antagonists, or 
proton pump inhibitors may be appropriate.  
Rarely, massive bleeding can result from injury to peripancreatic vascular 
structures, leading to hemorrhage into the retroperitoneum. The peripancreatic 
inflammatory process can also cause thrombosis of major gastrointestinal vessels 
and result in ischemic lesions involving the stomach, small intestine, or colon that 
can cause bleeding. Management of these complications of pancreatitis is similar 
to that involved when they occur in the absence of pancreatitis.  
Some patients with severe pancreatitis develop disseminated intravascular 
coagulation, but it rarely causes bleeding, and prophylactic heparinization is 
usually not indicated. 
Removal of precipitating factors, such as drugs or alcohol, is appropriate. 
Once the acute phase has been survived, usually by the end of the first week, and 
major organ failure is under control, then local complications become pre-eminent 
in the management of these patients.
 
An indication for operative intervention in acute pancreatitis is the drainage 
of an infected pancreatic necrosis. These patients require removal of as much as 
possible of the infected necrosis and drainage for the remaining viable exocrine 
tissue. Current opinion is against debridement in sterile necrosis unless it is 
accompanied by life threatening systemic complications
17
. 
A pancreatic abscess occurs 2 to 6 weeks after an initial attack of acute 
pancreatitis, in contrast to infected necrosis which occurs in the first few hours or 
days. Treatment consists of external drainage, either by surgical or percutaneous 
catheter based measures
17
. 
Treatment of Biliary Pancreatitis 
The presence of gallstones leading to choledocholithiasis is recognized as a 
major etiological factor worldwide. Endoscopic retrograde cholangio 
pancreatography (ERCP) has both diagnostic and most therapeutic utility in 
patients with biliary obstruction or cholangitis. By randomizing patients with AP to 
early ERCP versus no ERCP, both Neoptolemos and colleagues, and Fan and 
colleagues have showed a significant decrease in morbidity but there was no 
significant improvement in mortality with routine use of ERCP. A metacentric 
randomized control study in the ERCP group by Folsch and colleagues recently, 
have demonstrated increased complication rate and mortality rate, after excluding 
the patients with biliary sepsis or obstruction. It therefore, found that early ERCP 
may be harmful even in the absence of ongoing biliary obstruction. Magnetic 
resonance cholangio pancreatography (MRCP) is an additional alternative to ERCP 
as a diagnostic tool that avoids the risk of post procedure pancreatitis. 
In general, either early intervention (cholecystectomy) within the first 48 to 
72 hours of admission, or briefly delayed intervention (after 72 hours, but during 
the initial period of hospitalization) may be favored
8, 15
. Cholecystectomy with 
intra-operative CBD exploration is probably the best option for otherwise healthy 
patients with obstructive pancreatitis. However, patients who are at high risk for 
surgical intervention are best treated by endoscopic sphincterotomy, with clearance 
of stones by ERCP. 
Surgical Management: Indications and Timing 
There are very limited indications for surgical intervention; specifically, 
intervention may be needed to address the etiology of pancreatitis or its 
complications. Interventions, either surgical or endoscopic, to prevent recurrent 
gallstone pancreatitis are recommended in any patient with suspected 
choledocholithiasis. Delayed surgery is also, rarely needed for the treatment of 
local complications like pseudocysts
17
.  
 
Early surgical intervention can lead to significant hemorrhage from the 
pancreatic bed, which may difficult to control, due to the fact that endarteritis 
obliterans was incomplete and the delineation between viable & non-viable tissue 
might not be clearly made out.
 
 
 
 
 
 
 
 
 
 
 
 
 
Complications
17
: 
 
 
Complications may be classified as
15, 17
: 
I.  LOCAL: 
 Fluid collections 
Pancreatic ascites/pleural effusion 
Pancreatic pseudocyst 
Pancreatic necrosis 
Infected pancreatic abscess 
Hemorrhage/pseudo aneurysm 
 
 
 
II. REGIONAL: 
Venous thrombosis 
Paralytic ileus 
Intestinal obstruction 
Intestinal ischemia/necrosis 
Cholestasis 
III. SYSTEMIC: 
A. Pulmonary 
1. Pneumonitis, basal atelectasis 
2. ARDS 
3. Pleural effusion (L) 
B. Cardiovascular 
1. Hypotension 
2. Hypovolemia 
3. Sudden arrest &death 
4. Nonspecific ECG(ST-T wave) changes 
5. Pericardial effusion 
C. Hematologic 
1. Hemoconcentration 
2. Disseminated intravascular coagulopathy 
D. GI hemorrhage 
1. Acid peptic disease 
2. Gastric erosion 
3. Portal/splenic vein thrombosis with variceal bleed 
E. Renal 
1. Oliguria 
2. Azotemia 
3. Renal vessel thrombosis 
F. Metabolic 
1. Hyperglycemic state 
2. Hypocalcemic state 
3. Hyperlipidemia (triglyceridemia) 
4. Metabolic encephalopathy 
5. Sudden loss of vision (Purtscher's retinopathy) 
G. Central nervous system 
1. Acute psychosis 
2. Fat embolism occlusion 
3. Alcohol withdrawal syndrome (AWS) 
H. Fat necrosis 
1. Intra-abdominal saponification 
2. Subcutaneous tissue necrosis 
 
SCORING SYSTEMS IN ACUTE PANCREATITIS 
Pancreatitis is a serious disease with high morbidity and mortality rates. 
Some 80% were mild attack which recovers rapidly with conservative 
management. The rest of 20% were severe, with protracted course that needs 
intensive care and specialized management. Several predictors of severity are 
commonly used for this purpose
24
.
 
Scoring systems can be used to predict mortality, severity of disease and 
intensity of its complications. Prognostic factor analysis found to helpful in 
comparing the results, in-between the series of patients under study.
 
Several scoring scales exist that predict both mortality and morbidity in 
patients with acute pancreatitis.  
These systems include
25
: 
 Ranson’s criteria  
 Balthazar computed tomography (CT) grading 
 Imrie Glasgow coma score (GCS) 
 Bank’s clinical Criteria 
 Simplified acute physiology score(SAPS) 
 Marshall Multiple organ failure (MOF) score and 
 Acute physiology and chronic health evaluation (APACHE) I, II, III & O.  
The GCS and Ranson’s multiple scoring systems require 48 hours of data 
collection; however, APACHE can be calculated at any time and shows prognostic 
correlation with acute pancreatitis, as increasing scores are associated with poor 
prognosis. 
Once the acute pancreatitis has been diagnosed, assessment of severity is 
extremely important for execution of appropriate measures, preferably in an ICU 
setup with close monitoring.
 
1) RANSON’S CRITERIA27: 
In 1974, Ranson and Pasternak identified 11 parameters with prognostic 
significance. Mortality was related to the number of parameters present: 0-0.9% in 
patients with less than three positive prognostic signs, 10-20% in those with three 
to five positive signs, mortality increases to > 50% in those with > 7 positive 
signs
26
.
 
 
 
 
 
 Criteria for Pancreatitis not due to gall stones:
 
At admission or diagnosis: 
       Age more than55 years 
       WBC count > 16,000/mm
3 
       Blood sugar> 200 mg/dL 
Serum LDH> 350 IU/L 
AST > 250 U/dL 
During initial 48 hours: 
 Fall in hematocrit> 10 percentage points 
       BUN elevation > 5 mg/dL 
       Serum calcium level < 8 mg/dL 
       Arterial Po2 less than 60 mm Hg 
       Base deficit more than 4 meq/L 
       Estimated fluid sequestration > 6 L  
  
Gall stone induced pancreatitis:  
Recently, the cutoff values of these signs were modified in biliary 
pancreatitis. This limits the use of early prognostic signs; it now requires 
memorization of 18 separate parameters and etiology is not always known. 
Therefore the revisions for biliary pancreatitis have not had wide acceptance, and 
the original system is the one that is widely utilized
31
.  
On admission or diagnosis: 
       Age > 70 yrs 
       WBC count > 18,000/mm
3 
       Blood sugar> 220 mg/dL 
Serum LDH> 400 IU/L 
AST > 250 U/dL 
During initial 48 hours: 
       Fall in hematocrit greater than 10 percentage points 
       BUN elevation > 2 mg/dl 
       Serum ca
2+
 level < 8 mg/dl 
       Base deficit more than 5 meq/L 
       Estimated fluid sequestration > 4 L 
 
2) IMRIE’S PROGNOSTIC CRITERIA: 
During initial 48 hours 
       WBC count > 15000/mm
3
 
       Blood sugar > 10 mmol/L 
       Serum urea > 16 mmol/L (no response to IV fluids) 
       Po2 level < 60 mm Hg 
       Serum ca
2+
 level < 2 mmol/L 
      Lactic dehydrogenase> 600 IU/L 
AST / ALT>200µm/l 
       Serum albumin level < 32 g/L 
 
Ranson’s and Imrie’s scores indicate the severity at the time of admission 
and are not intended for monitoring the clinical course
27
. 
3) BANK’S CLINICAL CRITERIA: 
Cardiac        Shock, tachycardia, arrhythmia, ECG changes 
 
Pulmonary         Dyspnoea, basal rales, PO2< 60 mm Hg, ARDS 
 
Renal                 Urine output < 50 ml/h, rising BUN& creatinine 
 
Metabolic     Low Ca
2+
&pH;   albumin 
 
Haematological   HCT, DIC  
 
Neurological     cerebral Irritation & confused state 
 
GIT                         paralytic ileus, free fluid, hgic peritoneal tap 
 
 If the score was ≥ 1, the disease was severe in intensity. 
  
4) BALTHAZAR COMPUTED TOMOGRAPHY SEVERITY INDEX 
(CTSI): 
Emil J. Balthazar et al, developed CTSI, a grading system used to determine 
the acute pancreatitis severity
19, 33
.  
Prognostic Indicator Points Grade 
Pancreatic inflammation 
Normal pancreas  
Focal or diffuse enlargement of the pancreas  
Intrinsic pancreatic abnormalities with inflammatory changes in 
peripancreatic fat  
Single, ill-defined fluid collection or phlegmon  
Two or more poorly defined collections or presence of gas in or 
adjacent to the pancreas  
Pancreatic necrosis 
None  
≤ 30%  
> 30–50%  
> 50%  
 
0 
 
1 
 
2 
 
3 
 
4 
 
 
 
0 
2 
4 
6 
 
A 
B 
C 
D 
E 
 
Modified CT Severity Index
28 
Prognostic Indicator Points 
Pancreatic inflammation 
Normal pancreas  
Intrinsic pancreatic abnormalities with or without inflammatory changes 
in 
peripancreatic fat 
 
0 
 
2 
 
Pancreatic or peripancreatic fluid collection or peripancreatic fat 
necrosis  
 
Pancreatic necrosis 
None  
≤ 30%  
> 30%  
 
Extrapancreatic complications  
(one or more of pleural effusion, ascites, vascular 
complications, parenchymal complications, or gastrointestinal tract 
involvement) 
4 
 
 
 
0 
2 
4 
 
 
2 
 
5)   MODIFIED GLASGOW CRITERIA: 
This one was useful in both alcoholic and biliary pancreatitis
27
. 
The score ≥ 3 means severe disease requires ICU care. 
 P - PaO2 <8kPa or < 60 mmhg 
 A - Age more than 55 years old 
 N - Neutrophilia with WBC count>15x109/L 
 C - Ca2+<2mmol/L or < 8 mg/dl 
 R - Renal function, Urea >16mmol/L or > 45 mg/dl 
 E – Enzymes:- serum LDH >600 IU/L; AST>200 IU/L 
 A - Albumin <3.2g/dL 
 S - Sugar: >10mmol/L or  >180 mg/dl 
6)  CRITERIA FOR ORGAN FAILURE BASED ON MARSHALL 
SCORINGSYSTEM: 
 
 
 According to this scoring system score of ≥ 2 indicates presence of organ 
failure. These scores were calculated within 72 hours of admission into the 
hospital. The organ failure was classified as
27
: 
 Transient (less than 48 hrs.)  
 Persistent (more than 48 hrs.) 
7)  THE APACHE (ACUTE PHYSIOLOGICAL AGE AND CHRONIC 
HEALTH EVALUATION) SYSTEM 
Knaus et al (1981) proposed a scoring system APS for classifying the 
patients according to the disease severity
29
. This was based on recording the 
abnormal physiological parameters. In consultation with a large number of 
intensive care specialists, they devised a scale. That included an acute 
physiological assessment, which examined abnormality among 34 possible 
measurements obtained during the 1
st
 day of admission to the intensive care units. 
A number from zero to four was assigned to each measurement according to how 
far from normal the measurements vary. 
When multiple values for the same measurement were available, the worst 
was chosen. The final score, which ranged from zero to 124, indicates how far 
from normal homeostasis a patient had strayed because of acute illness.
 
The true APACHE score was more difficult to calculate because of practical 
problems like collection of large number of variables. Also under the rules of 
APACHE system any unmeasured variable was assumed to be normal and 
weighted as zero. This gave rise to questions about the model’s general 
applicability. Another major criticism of original APACHE system was that the 
variables were chosen by a group of physicians and there was a potential of bias. 
These inaccuracies in the original APACHE system prevented its widespread use. 
However, it did serve as the prototype for the development of two subsequent 
systems. 
APACHE II 
In 1985, Knaus et al developed this scoring system based on 12 
physiological variables
30
. To calculate the score, 0 - 4 values were assigned to all 
the 12 physiological and laboratory values with 0 being normal and 4 being the  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
most abnormal. APACHE II did not strictly depend on ICU setting only but it was 
found to be as reliable as APS outside the ICU settings. The age and chronic health 
problems were included in this score as they reflect the physiological reserve 
status.  
APACHE II Score as published by Knaus et al is composed of three parts: 
1) Acute Physiological Score (0 to 60 points)  
2) Age points (0 to 6 points) 
3) Chronic health points (0 to 5 points).  
Range of potential score is 0 to 71 but scores above 40 are uncommon. Score 
above 30 are associated with mortality rate of at least 70%. Roumen et al, in their 
study on acute hemorrhagic necrotising pancreatitis, concluded that of Ranson, 
Imrie, Multiple organ failure (MOF) and Sepsis sensitivity score (SSS), APACHE 
II is the best for grading the severity of disease on admission
32
. It is well suited for 
stratification of patients and comparisons of treatment methods. 
The advantages are:
 
1) Objective determination of AP within few hours of admission, which might 
helpful in detection of cases for ICU care or for clinical trial. 
2) Use of routine laboratory tests available 24 h a day. 
3) Ability to be recalculated daily. Sequential monitoring of APACHE II 
enables determination of improvement or deterioration in the physiologic 
status of the patient. Over the initial 48 h, the score increase significantly in 
those with severe disease (median increase three points) but decrease 
(median decrease one point) in patients with mild pancreatitis. Thus this 
might be useful for follow up of the disease course and helps to assess the 
therapeutic response. 
4) This score was used universally for all serious illnesses, thereby avoiding 
the need for a separate grading for acute pancreatitis. 
 
The major drawbacks of APACHE II are: 
1) Complexity and poor feasibility 
2) The ideal ‘cut-off’ score for APACHE II in acute pancreatitis remains to be 
determined 
3) As shown by Wilson et al, the cut-off scores having the greatest prognostic 
values on admission are different from the peak scores during the hospital 
course. The use of a single cut-off score APACHE II ≥ 9, as suggested by 
Larvin and McMohan needs to be validated in more studies. 
4) Influenced by delay during presentation or the type of resuscitation 
treatment. 
5) APACHE II generally underestimates mortality in many series of critically 
ill surgical patients as pre-ICU resuscitation not taken into account and 
young patients score few points despite severe pancreatitis. 
6) APACHE II mortality predictions were based on treatment that lasts for 20 
years ago. 
APACHE III 
In 1991, Knaus et al presented a revised and improved form of APACHE-II 
and termed it as the APACHE-III prognostic system
34
.  
The following variables were included in this score; blood urea, urine 
output, Sr. albumin, Sr. bilirubin, blood glucose, pCO2 in comparison to 
APACHE-II.  
APACHE III is regarded as a good prognostic scoring system by using it 
serially and sequentially in acute pancreatitis. APACHE III score shows significant 
differences in mild and severe AP and correlates well with severity
35
. APACHE 
evaluation proves very suitable for serial monitoring of patients and gives an 
objective indication of progress in the individual patient. Williams et al found that 
an APACHE III score >30 indicated a much higher morbidity and mortality rate
36
. 
Overall, the APACHE III score appeared to be inferior to its predecessor
37
.It 
is expensive to calculate APACHE III scores daily so it is not feasible for 
financially constrained ICUs. As compared to APACHE II, the data collection was 
very much complex, and it was not accurate for predicting the risk in post-op 
cases. 
8) BISAP (The bedside index for severity in AP):  
This new scoring system has been developed recently for early detection of 
patients with risk of in hospital mortality
1
.  
The BISAP score has been developed and validated retrospectively on a 
large population based study, done by Cardinal Health Clinical Outcomes Research 
Database, Marlborough, USA
38
.  
This score was published recently for clinical and research purpose, for its 
accuracy and reliability in patient stratification.   
The BISAP includes
38
:  
1) Blood urea nitrogen (BUN) >25 mg / dl. 
2) Impaired mental status (GCS < 15).  
3) SIRS. 
4) Age >60 years. 
5) Pleural effusion.  
 
SIRS was defined by presence of two or more of the following criteria:  
1) Pulse rate > 90/min. 
2) Respiratory rate > 20/min or PaCO 2 < 32 mm Hg.  
3) Temperature >100.4 F or < 96.8 F / < 36 or > 38 ° C. 
4) WBC count >12,000 or < 4,000 cells/mm3, or presence of more than 
10% immature blasts. 
 
(SIRS - Systemic Inflammatory Response Syndrome) 
One point will be given for each variable present for a total of 5, score ranges from 
0 to 5.  
The presence of a pleural effusion was determined by a CT scan, chest 
radiograph or abdominal ultrasound obtained within 24 h of presentation. Imaging 
obtained within 24 h of presentation at the hospital of origin for transferred patients 
was also collected and reviewed.  
A BISAP score of three or more has been found to have high mortality and have 
predicted the necrosis and organ failure very well
39
. 
ADVANTAGES: 
1. Simple and easy to calculate, usually done at the time of admission or within 
24 hrs. Of hospitalization
40
. 
2. The scores prediction ability was tested across 390 hospitals among large 
number (36,248) of populations, in contrast to other studies which were 
based on small number patients. 
3. This predicts in-hospital mortality. 
DISADVANTAGES: 
1. The Glasgow Coma Scale used for evaluating mental status was subject to 
interobserver variation. 
2. It could not discriminate transient from persistent organ failure within 24 
hrs. Of hospitalization.  
3. This could not predict the preventable complications of acute pancreatitis 
like any other scoring system. 
AIMS AND OBJECTIVES OF THE STUDY 
 To evaluate the role of BISAP score in place of traditional APACHE II 
scoring system in analyzing severity and early treatment intervention. 
 Stratification of the patients with acute pancreatitis according to their scores 
observed at the time of hospitalization. 
 To correlate the outcome of the study with the scores observed, in terms of 
disease severity and mortality. 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
Study design: Comparative Analytical study. 
Setting: Department of General Surgery, Govt. Stanley Medical College and 
Hospital, Chennai. The study was conducted after obtaining the Institutional 
Ethical Committee approval (annexure 2). 
Inclusion criteria: 
 Age >20 years including both sexes. 
 Serum amylase/ Serum lipase equal to or more than 3 times the upper limit 
of normal. 
 Radiological evidence of presence of acute pancreatitis. 
Exclusion criteria: 
 Patients were excluded from the study if they were younger than 20 years. 
 Proven cases of chronic pancreatitis. 
 Hereditary pancreatitis. 
 Patients with comorbidities like COPD, renal impairment, 
immunosuppressive state, etc. 
 Traumatic pancreatitis associated other visceral injuries. 
 
 
Methods: 
 First 100 patients attending the surgical emergency ward with clinical 
features of Acute Pancreatitis are evaluated clinically and subjected to 
laboratory and radiological investigations as per the designed proforma 
(annexure 1). Data pertinent to the scoring systems will be recorded within 
24 h of admission to the hospital. 
 Once diagnosis is established the patient disease severity will be assessed by 
following two scoring systems 
 BISAP 
 APACHE II 
Statistical Analysis:   Appropriate statistical tools. 
For each of 100 patients included in the study, APACHE II and BISAP 
scores were calculated by using the APACHE II prognostic system in the manner 
described by Knaus et al and the Cardinal Health Database system for BISAP 
scoring. 
Patients were classified to have mild or severe acute pancreatitis according 
to the definitions set by the Atlanta Classification guidelines (1992)
42
: 
Severe attack--Criteria for severity included: 
1) presence of one or more local complications:  
 Pancreatic necrosis 
 Pancreatic abscess 
 Pancreatic pseudo cyst. 
2) Presence of one or more organ failures: 
 Shock (systolic BP< 90 mm Hg). 
 Pulmonary insufficiency (PaO2< 60 mm Hg on room air). 
 Renal failure (Sr. creatinine > 2mg/dl after fluid replacement). 
 Gastrointestinal bleeding (> 500 ml estimated loss of blood within 24 
hrs.). 
 DIC (thrombocytopenia and hypofibrinogenemia and fibrin split 
products). 
 Severe hypocalcemia (<8 mg/dl). 
Survivors were defined as patients discharged alive from the hospital and 
non-survivors were those who died from pancreatitis or its complications during 
hospitalization.  
Biliary Pancreatitis was presence of gall stones/biliary sludge in the gall 
bladder or bile duct, which was documented by any radiological methods. 
Alcoholic Pancreatitis was considered, when the patient found to have regular high 
intake of alcohol daily, or if there was binge of alcohol consumption prior to the 
onset of illness and has no signs of other etiologies present. Idiopathic pancreatitis 
was the one with no identifiable etiological factor based on the history, or after 
initial investigations. 
Patients were observed prospectively until discharge or death. 
APACHE II score of ≥ 9 and BISAP score of ≥ 3 were expected to predict 
severe Acute Pancreatitis. 
 
OBSERVATION &RESULTS 
This study was conducted in the department of general surgery, Govt. 
Stanley Medical College & Hospital, Chennai for a period of one year. The 100 
persons with features of acute pancreatitis who fulfilled the inclusion cr iteria were 
enrolled in this study after obtaining an informed consent. 
Table: 1 Age distribution 
 
Age Range (years) No. of patients Percentage (%) 
21yrs - 30yrs 22 22 
31yrs - 40yrs 25 25 
41yrs - 50yrs 37 37 
51yrs - 60yrs 14 14 
>60yrs 2 2 
Total 100 100 % 
 
 
The age group of patients enrolled in this study ranges from 20 to 80 yrs. 
The peak incidence of the disease was noted in the 4
th
 decade  
of life. 
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Table: 2 Gender distributions: 
 
Sex No. of patients Percentage (%) 
Male 91 91 
Female 9 9 
Total 100 100 
 
Out of 100 patients enrolled in this study there were 91 male and 9 female 
patients.  
Male: Female ratio-10.1:1 
 
 
 
Table: 3 Age wise Sex Distribution: 
 
Age group 
(years) 
Sex 
Male Female Total 
N % N % N % 
21 - 30 19 20.9 3 33.3 22 22.0 
31 - 40 24 26.4 1 11.1 25 25.0 
41 - 50 34 37.4 3 33.3 37 37.0 
51 - 60 12 13.2 2 22.2 14 14.0 
>60 2 2.2 0 .0 2 2.0 
Total 91 100.0 9 100.0 100 100.0 
 
Mean age group of males: 41.23 years. 
Mean age group of females: 40.67 years. 
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 Table: 4 Hospital Stay: 
 
Days in hospital No. of patients Percentage (%) 
1day - 7days 33 33 
8days - 14 days 37 37 
15days - 21days 20 20 
22days - 28days 8 8 
>28 days 2 2 
Total 100 100 
The length of hospital stay ranges from 1 day to 32 days. 
The mean length of hospital stay was 12.03 ± 6.8 days. 
 
 
Table: 5 Clinical features: 
 
Symptoms No. of patients Percentage (%) 
Pain abdomen 95 95 
Fever 31 31 
Vomiting 25 25 
Jaundice 14 14 
Abdominal distension 13 13 
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 On clinical presentation, 95% of patients were presented with abdominal 
pain as chief complain. Rest of 5% who didn’t have abdominal pain had vomiting 
and fever as presenting symptoms.  
 
Table: 6 Etiologies: 
 
Etiology No. of patients Percentage (%) 
Alcohol 49 49 
Gall stone disease 23 23 
Drug induced 2 2 
Hypertriglyceridemia 3 3 
Trauma  2 2 
Idiopathic  21 21 
 
History of consumption of alcohol and the possibility of it being the 
etiological factor were found in 49 patients. Gall stone disease was attributed in 23 
patients. Hyperlipidemia and drugs as causative factor presented in 3 & 2 patients, 
respectively. There was clear cut history of blunt trauma with CT scan showed 
isolated pancreatic laceration presented in 2 cases. No cause could be attributed in 
rest of the 21 patients.  
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Table: 7 Outcomes: 
 
 
 Out of 100 patients, 86 patients presented with mild acute pancreatitis and 
14 patients presented with severe acute pancreatitis. Out of 14 with severe attack, 4 
patients expired. 
 In mild group the BISAP score ranges from 0 to 2, APACHE II score ranges 
from 0 to 8. 
 In severe attack group the BISAP score ranges from 3 to 5, APACHE II 
score ranges from 9 to 31. 
 The severity of acute pancreatitis was assessed by correlating the scoring 
systems with outcome in terms of organ failure, pancreatic necrosis and mortality, 
based on revised Atlanta classification system of acute severe pancreatitis.  
 
 
  
Number of 
patients 
 
Organ failure 
 
Pancreatic 
Necrosis 
 
 
Mortality 
 
        BISAP 
< 2 86 3 2 0 
≥ 3 14 10 9 4 
    APACHE II 
< 9 58 1 1 2 
≥ 9 42 13 10 2 
Table: 8 Correlation of BISAP & APACHE II with severity 
 
 BISAP < 2 APACHE < 9    P VALUE 
 
ORGAN 
FAILURE 
 
4 
 
1 
 
 
0.2275 
 
 
0.6334 
 
NECROSIS 
 
2 
 
1 
 
       
 
 
0.7286 
 
MORTALITY 
 
0 
 
 
2 
 
0.9629 
 
 
0.3265 
 
 
 
Out of 86 patients presented with BISAP score <2, organ failure, pancreatic 
necrosis were presented in 4 & 2 patients respectively. There was no mortality in 
this group. 
 Of 58 patients presented with APACHE II score <9, 1 patient developed 
organ failure and 1 patient developed pancreatic necrosis. There were 2 mortalities 
in this group. 
 Thus, using Chi
2
test, there was no significant difference between these two 
scores [BISAP <2, APACHE II <9] in predicting the organ failure (p=0.633), 
necrosis(p=0.728) and mortality (p=0.326), respectively in mild AP. 
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 Table: 9 Correlation of BISAP & APACHE II with severity 
 
 BISAP ≥ 3 APACHE ≥ 9    P VALUE 
 
ORGAN 
FAILURE 
 
10 
 
 
13 
 
5.5336 
 
 
0.0187 
 
NECROSIS 
 
9 
 
10 
 
       
 
 
0.0145 
 
MORTALITY 
 
4 
 
2 
 
3.9822 
 
 
0.046 
 
 
 
 
 Here, 10 out of 14 patients with BISAP >3 and 13 out of 42 patients with 
APACHE II >9, developed organ failure. Thus using Chi
2
 test, the occurrence of 
organ failure correlates well with outcome with a p value <0.0187. 
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 Here, 9 out of 14 patients with BISAP >3 and 10 out of 42 patients with 
APACHE II >9, developed pancreatic necrosis. Thus, using Chi
2
 test, development 
of necrosis correlates well with outcome with p value <0.0145. 
 
There were 4 deaths in severe acute pancreatitis group. Of them, 2 had 
BISAP score of 4 & APACHE II score of 8 and the other 2 had BISAP score of 5 
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& APACHE II score of >20 respectively. Thus, using Chi
2
 test, the disease severity 
correlates well with mortality with p value <0.046. 
Organ failure: 
ROC Curve Analysis to find the best cut-off point for BISAP score and 
APACHE II score to Organ failure: 
 
 
Area under the Curve by BISAP score = 0.907 
Area under the Curve by APACHE score = 0.830 
The ROC curve analysis predicted that the BISAP score of 3 or more will predict 
the organ failure. 
 
 
 
 
 
Sensitivity and Specificity analysis: BISAP score. 
 Organ Failure Total 
Yes No 
BISAP  
Score 
≥  3 10 4 14 
< 3 4 82 86 
Total 14 86 100 
 
Parameter Estimate Lower - Upper 95% 
CIs 
Sensitivity 71.43% 45.35, 88.28 
Specificity 95.35% 88.64, 98.18 
Positive Predictive Value 71.43% 45.35, 88.28 
Negative Predictive Value 95.35% 88.64, 98.18 
Diagnostic Accuracy 92.00% 85.00, 95.89 
 
 
The ROC curve analysis predicted that the APACHE II score of 10 or more 
will predict the organ failure. 
Sensitivity and Specificity analysis: APACHE II score. 
 
 Organ Failure Total 
Yes No 
APACHE 
Score 
≥ 10 11 22 33 
< 10 3 64 67 
Total 14 86 100 
 
 
 
 
 
 
 
 
 
 
 
Parameter Estimate Lower - Upper 95% 
CIs 
Sensitivity 78.57% 52.41, 92.43 
Specificity 74.42% 64.29, 82.46 
Positive Predictive Value 33.33% 19.75, 50.39 
Negative Predictive Value 95.52% 87.64, 98.47 
Diagnostic Accuracy 75.00% 65.70, 82.45 
 
The ROC analysis for prediction of organ failure shows BISAP score has 
diagnostic accuracy of 92% compared to 75% with APACHE II score.  
Necrosis: 
 ROC Curve Analysis to predict the best cu-off point for BISAP score and 
APACHE II score to NECROSIS: 
 
 
Area under the Curve by BISAP score = 0.901 
Area under the Curve by APACHE score = 0.852 
 
The ROC curve analysis predicted that the BISAP score of 3 or more will 
predict the NECROSIS. 
Sensitivity and Specificity analysis: BISAP score: 
 NECROSIS Total 
Yes No 
BISAP  
Score 
≥  3 9 5 14 
< 3 2 84 86 
Total 11 89 100 
 
 
Parameter Estimate Lower - Upper 95% CIs 
Sensitivity 81.82% 52.30, 94.86 
Specificity 94.38% 87.51, 97.58 
Positive Predictive Value 64.29% 38.76, 83.66 
Negative Predictive Value 97.67% 91.91, 99.36 
Diagnostic Accuracy 93.00% 86.25, 96.57 
 
The ROC curve analysis predicted that the APACHE score of 11 or more 
will predict the NECROSIS. 
Sensitivity and Specificity analysis: APACHE II score. 
 NECROSIS Total 
Yes No 
APACHE 
Score 
≥ 11 10 20 30 
< 11 1 69 70 
Total 11 89 100 
 
 
 
Parameter Estimate Lower - Upper 95% 
CIs 
Sensitivity 90.91% 62.26, 98.38 
Specificity 77.53% 67.82, 84.96 
Positive Predictive Value 33.33% 19.23, 51.22 
Negative Predictive Value 98.57% 92.34, 99.75 
Diagnostic Accuracy 79.00% 70.02, 85.83 
 
 The ROC analysis for prediction of necrosis shows BISAP score has 
diagnostic accuracy of 93% compared to 79% with APACHE II score.  
Mortality: 
 ROC Curve Analysis to find the best cu-off point for BISAP score and 
APACHE II score to predict mortality: 
 
Area under the Curve by BISAP score = 0.984 
Area under the Curve by APACHE II score = 0.779 
The ROC curve analysis predicted that the BISAP score of 4 or more will 
predict the non-survival status. 
Sensitivity and Specificity analysis: BISAP score: 
 MORTALITY Total 
Yes No 
BISAP  
Score 
≥  4 4 4 8 
< 4 0 92 92 
Total 4 96 100 
 
Parameter Estimate Lower - Upper 95% CIs 
Sensitivity 100.00% 51.01, 100.00 
Specificity 95.83% 89.77, 98.37 
Positive Predictive Value 50.00% 21.52, 78.48 
Negative Predictive Value 100.00% 95.99, 100.00 
Diagnostic Accuracy 96.00% 90.16, 98.43 
 
The ROC curve analysis predicted that the APACHE score of 8 or more will 
predict the non-survival status. 
Sensitivity and Specificity analysis: APACHE II score: 
 MORTALITY Total 
Yes No 
APACHE Score ≥  8 4 45 49 
< 8 0 51 51 
Total 4 96 100 
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SCORING SYSTEM 
SURGICAL INTERVENTION 
Incorrectly
predicted
Parameter Estimate Lower - Upper 95% CIs 
Sensitivity 100.00% 51.01, 100.00 
Specificity 53.13% 43.22, 62.79 
Positive Predictive Value 8.163% 3.22, 19.19 
Negative Predictive Value 100.00% 93.00, 100.00 
Diagnostic Accuracy 55.00% 45.24, 64.39 
Likelihood ratio of a 
Positive Test 
2.133 2.042 - 2.228 
The ROC analysis prediction for mortality shows BISAP score has 
diagnostic accuracy of 96%, whereas APACHE II score has 55%. 
 
Management: 
 All except four patients managed conservatively. 
 Three patients underwent emergency laparotomy. Two patient had traumatic 
injury to pancreas which was initially managed conservatively later they developed 
severe pancreatitis with intra-abdominal abscess, that required laparotomy and 
drainage procedure.  
 
 
 
 
 
 
  
One patient with severe disease have developed pseudocyst, underwent 
laparotomy and internal drainage. 
Another patient who had severe pancreatitis underwent necrosectomy 
initially& has developed pancreatic fistula later, which was managed by pancreatic 
duct stenting. 
The BISAP score has predicted all the four patients correctly as severe 
pancreatitis, whereas APACHE II score predicted only two of the cases as severe 
pancreatitis. 
  
Table: 10 Complications: 
 
Complication No. of patients  Percentage (%) 
Acute renal failure 5 35.7 
Respiratory failure 1 7.14 
Pancreatic necrosis 11 78.5 
Intra-abdominal abscess 1 7.14 
Upper gastrointestinal bleeding 1 7.14 
Multi-organ dysfunction syndrome 3 21.4 
Septicemia 2 14.2 
Encephalopathy 1 7.14 
Portal vein thrombosis 1 7.14 
Disseminated intravascular 
coagulation 
1 7.14 
Pancreatic Fistula 1 7.14 
Pseudo cyst 1 7.14 
Hypocalcemia 1 7.14 
 
All the 14 patients with BISAP score > 3, developed major organ failure.  
Local complications like pancreatic necrosis developed in 78.5% and 7.1% 
developed abscess, pseudo cyst and fistula formation.  
35.7% developed acute renal failure, 21.4% developed MODS, 14.2% 
developed septicemia and 7.1% developed rest of the complications. 
  Of 4 deaths, 3 patients died of multi organ failure and 1 died of DIC with 
septicemia. 
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Fatal outcome: 
 Out of 100 patients, there were 96 survivors and 4 non-survivors. 
The mean age of non-survivors was 60 yrs. 
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DISCUSSION 
Acute pancreatitis is a common disorder with wide spectrum of illnesses. 
Severe acute pancreatitis having high morbidity and mortality rate, multiple 
interventions have been tried to prevent this. Early hospitalization may be 
beneficial to identify those who require aggressive interventions to prevent the 
severe attack of AP. 
 In this study, the two different scoring systems (BISAP and APACHE II) 
were compared and analyzed to assess the severity in patients with acute 
pancreatitis. An attempt also made to compare this study with previous similar 
studies done by others. 
Acute pancreatitis found to be 10 times more common in males than females 
in this study. This result didn’t match with previous study results, Vikesh K. Singh 
et al
38
 (6:1), Papachristou et al
1
 (5.1:1). This could be explained by the fact that, in 
this study alcohol has found to be most common etiological factor and it’s more 
common in males. 
Patients less than 20 years of age were excluded in this study, because the 
normal values of heart rate and respiratory rate are higher at younger age group. 
So, if these patients had been included in this study, they could have got higher 
scores incorrectly and could have predicted incorrectly as at risk for developing 
severe pancreatitis, even with mild disease. 
In this study, the mean age was 41.18 years which matches with the study of 
Sarath et al (40.8 yrs), nearly matches with Vikesh K. Singh et al
38
 (49.6 yrs), 
Papachristou et al
1
 (51.7 yrs). 
The mean age of non-survivors in this study was found to be 60 years as 
compared to survivors being 41.23 years. Taking 60 yrs of age as cut-off value, 
increasing age was found to be correlated well with increasing incidence of 
mortality. Thus age is considered as a significant contributory factor in predicting 
the outcome of severe acute pancreatitis. 
The most common etiological factor in this study was alcohol (49%) & 
matches with Bidarkundi et al
43
(46.67%), but didn’t correlate with results of 
Vikesh K. Singh et al
38
 (21.4%), Papachristou et al
1
 (14%) wherein gall stone 
disease found to be the most common cause, 27% & 36% respectively. 
The mean length of hospital stay was 12.03 ± 6.8 days in this study. In this 
study, increasing BISAP & APACHE II scores was correlated well with the 
duration of hospital stay. 
The most common presentation was predominantly abdominal pain (95%), 
followed by fever (31%), vomiting (25%) & other manifestations. 
In this study, 86 patients were diagnosed to have mild acute pancreatitis and 
14 patients found to have severe acute pancreatitis. All the 14 patients were 
correctly predicted by BISAP Score. The severity was assessed by correlating the 
scores with three factors: organ failure, necrosis and mortality.  
The ROC analysis for organ failure showed BISAP score has AUC of 0.907, 
specificity of 95.35%, PPV of 71.4%, NPV 95.3% and diagnostic accuracy of 
92%; whereas APACHE II score has AUC 0.830, sensitivity of 78.5%, specificity 
of 74.4%, PPV of 33.3%, NPV of 95.5% and diagnostic accuracy of 75%. This 
correlates well with the study by Papachristou et al
1
 where AUC (0.81, 0.78), 
specificity (92.4%, 71.9%), PPV (57.7%, 40%) and NPV (84.3%, 90.1%), for 
BISAP and APACHE II scores, respectively. Thus by using Chi
2
 test, BISAP ≥ 3 
has  
significant correlation with prediction of the occurrence of organ failure (p < 0.01), 
which matches well with study by Vikesh k. Singh et al
38
 and B U Wu et al
41
. 
In this study, 9/14 with BISAP > 3 and 10/42 with APACHE II > 9 
developed pancreatic necrosis. The ROC analysis for prediction of necrosis has 
AUC (0.901, 0.852), sensitivity (81.8%, 90.9%), and specificity (94.3%, 77.5%), 
PPV (64.2%, 33.3%), NPV (97.6%, 98.5%) and diagnostic accuracy (93%, 79%) 
for BISAP and APACHE II scores, respectively. This correlates with the previous 
study by Papachristou et al
1
, where AUC (0.78, 0.72), specificity (90.6%, 68.5%), 
PPV (46.2%, 29.2%), NPV (84.9%, 90.1%), for BISAP and APACHE II scores, 
respectively. Thus by using Chi
2
 test, BISAP ≥ 3 has significant correlation with 
prediction of pancreatic necrosis (p < 0.01); this again matches with the study by 
Vikesh k. Singh et al
1
.  
In this study, 4% underwent surgical intervention which comparable with 
Sarath et al. 
In this study, 4 patients with severe acute pancreatitis were expired. All four 
deaths were correctly predicted by BISAP score. Three patients were expired due 
to MODS and one patient expired due to DIC with septicemia. The ROC analysis 
for prediction of mortality has AUC (0.984, 0.779), sensitivity (100%, 100%), 
specificity (95.8%, 53.1%), PPV (50%, 8.1%), NPV (100%, 100%) and diagnostic 
accuracy (96%, 55%), for BISAP and APACHEII scores, respectively. This 
matches well with B U Wu et al
41
, Papachristou et al
1
, where specificity (87.6%, 
65.7%), PPV (15.4%, 10.8%), NPV (98.1%, 100%), for BISAP and APACHE II 
scores, respectively. Thus by using Chi
2
 test, BISAP ≥ 3 was found to be 
significantly associated (p < 0.04) with high mortality than APACHE II score by 
ROC. It was found to have high specificity, PPV and NPV for mortality. This 
again matches well with previous study by Vikesh k. Singh et al
38
 and Papachristou 
et al
1
. 
In this study, 35.7% developed acute renal failure, 21.4% developed MODS, 
14.2% developed septicemia and 7.1% developed other complications like ARDS, 
UI bleed, etc. These complications were more likely seen in patients with BISAP ≥ 
3 and APACHE ≥ 9 hence concluded that these are the patients in high risk group, 
who requires intensive monitoring and probably early intervention if necessary.  
BISAP score was found to have more sensitivity, specificity, positive and 
negative value, and diagnostic accuracy than APACHE II score in predicting the 
severity of acute pancreatitis. Hence, BISAP score found to predict more number 
of patients, likelihood of progressing to severe disease. Larven et al stated in their 
study that, a prognostic scoring assay should preferably have high positive and 
negative predictive values or high negative predictive value to assess the severity 
of acute pancreatitis
44
. Hence, BISAP is considered as better score in assessing the 
severity than APACHE II score.    
 
 
Limitations of this study are: 
 Small number of patients in this study. 
 The etiology in this study were found to be different from worldwide 
accepted one, hence might not be correct to compare with other studies. 
 The GCS score used to assess the mental status of the patient got admitted 
were subject to interobserver variation. 
 Various factors associated with the disease like cholangitis, alcohol 
withdrawal may interfere with the assessment of physiological scores, which 
may leads to difference in the results. 
 Recently, it has been suggested that severe acute pancreatitis may have 
variable disease progression; therefore the lack of predictability might be 
associated with this disease variability.     
 Variation in timing of presentation of patients to the hospital after onset of 
symptoms may interfere with assessment of the scoring systems. 
 
 
 
CONCLUSION AND SUMMARY 
 From this study, Alcohol (49%) was found to be the most common 
etiological factor for acute pancreatitis. 
 Males were most commonly affected than female with a ratio of 10:1. 
 The most common age groups of patients affected were in 4 th decade of life. 
 The overall mortality in patients with severe acute pancreatitis was 4%. 
 The BISAP score predicted the mortality significantly over the APACHE II 
score in patients with severe acute pancreatitis. 
 The BISAP score predicted the disease severity significantly over the 
APACHE II score in patients with acute pancreatitis. 
 
From this study, we conclude that the BISAP score could be a simple and 
accurate clinical scoring system for the evaluation of disease severity in acute 
pancreatitis.  
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No. NAME IP No AGE SEX Age Temp HR RR 0xy. MAP Na+ K+ HCo3 Crea. PCV WBC GCS Chronic APACHE BUN GCS SIRS AGE PE BISAP
OUT
COME OF pNEC. MANAGEMENT Comp. LOH ETIOLOGY
ABD. 
PAIN VOMI. FEV. JAUN.
ABD. 
DIS.
1 JEGAN 38392 45 MALE 2 0 0 1 1 0 2 0 2 2 2 0 3 0 15 0 1 1 0 0 2 Alive CONSERVATIVE 18 ALCOHOL + – – – –
2 ANANDHAN 37332 42 MALE 0 0 0 0 0 0 0 0 0 2 0 0 2 0 4 0 1 1 0 0 2 Alive CONSERVATIVE pNEC 12 ALCOHOL + + – – –
3 DHANAPAL 34612 55 MALE 3 0 0 1 0 0 2 0 2 3 0 0 3 0 14 0 1 1 0 0 2 Alive CONSERVATIVE 17 ALCOHOL + + + – –
4 MURUGAN 37377 40 MALE 0 1 2 3 1 2 2 0 4 3 3 0 2 0 23 1 1 1 0 1 4 ALIVE + CONSERVATIVE ARF 28 ALCOHOL + + + + –
5 PREMKUMAR 26628 29 MALE 0 1 0 0 0 0 3 2 2 0 0 0 0 0 8 1 0 1 0 0 2 Alive CONSERVATIVE 13 GSD + – – - –
6 CHELLAKANNU 26301 34 MALE 0 0 0 0 0 0 0 0 3 0 0 0 2 0 5 0 1 1 0 0 2 Alive CONSERVATIVE 19 ALCOHOL + + + – –
7 RAJENDRAN 46982 46 MALE 0 3 2 3 1 2 2 2 3 3 1 0 4 5 31 1 1 1 0 1 4 DEATH + MODS 3 ALCOHOL + + + – +
8 RAFIQ 18441 50 MALE 2 0 0 1 0 3 0 1 0 0 2 0 2 0 11 0 1 1 0 0 2 Alive CONSERVATIVE 22 ALCOHOL + – – – –
9 PRAKASH 23987 29 MALE 0 0 3 1 0 0 0 1 2 2 0 0 3 0 12 0 1 1 0 0 2 Alive CONSERVATIVE 16 GSD + + + – –
10 ANANDHAN 6918 47 MALE 2 0 0 1 0 2 0 1 0 0 0 0 2 0 8 1 1 1 0 0 3 Alive + SURGERY
pNEC
PF 13 ALCOHOL + – – – –
11 GOPINATH 26635 25 MALE 0 1 0 1 0 0 0 1 2 2 0 0 2 0 9 0 1 1 0 0 2 Alive CONSERVATIVE 17 ALCOHOL + – – – –
12 ARUNPRASATH 39206 32 MALE 0 0 0 0 1 0 2 2 2 0 4 0 2 0 13 1 1 0 0 0 2 ALIVE CONSERVATIVE 12 ALCOHOL + – – – –
13 GOPINATH 22530 31 MALE 0 0 0 0 0 0 3 0 2 0 0 0 0 0 5 0 0 1 0 0 1 Alive CONSERVATIVE 7 GSD + – – – –
14 PRABU 22444 31 MALE 0 3 0 0 0 2 2 1 2 0 0 0 1 0 11 0 1 1 0 0 2 Alive CONSERVATIVE 8 IDIOPATHIC + – – - –
15 SENTHIL PANDI 6923 32 MALE 0 0 0 0 0 0 0 2 0 0 0 0 0 0 2 0 0 1 0 0 1 Alive CONSERVATIVE 6 ALCOHOL + - - – -
16 PRABU 17439 21 MALE 0 0 0 1 0 0 0 1 0 0 0 0 0 0 2 0 0 1 0 0 1 ALIVE CONSERVATIVE 7 ALCOHOL + – – – –
17 ARIVAZHAGAN 3E+05 46 MALE 2 0 0 0 0 0 0 1 0 0 0 0 1 0 4 0 1 1 0 0 2 ALIVE CONSERVATIVE 7 IDIOPATHIC + – – – –
18 KANNAN 26665 32 MALE 0 1 2 0 0 0 2 2 2 0 0 0 0 0 9 1 0 1 0 0 2 Alive CONSERVATIVE 16 ALCOHOL + – + + –
19 PILLAYARSAMY 37807 49 MALE 2 0 2 0 0 0 0 0 1 0 0 0 0 2 5 0 1 0 0 0 1 Alive CONSERVATIVE 6 ALCOHOL + – – – –
20 VIJAYAKUMAR 36395 35 MALE 0 0 0 0 0 0 0 0 2 2 0 0 0 0 4 0 0 1 0 1 2 Alive CONSERVATIVE 9 ALCOHOL + + – - –
21 KRISHNAN 37386 55 MALE 3 0 0 1 0 3 3 0 0 0 0 0 0 0 10 0 0 1 0 0 1 Alive CONSERVATIVE 9 GSD + – - – –
22 MURUGAN 39214 35 MALE 0 0 0 0 0 0 2 2 0 0 0 0 0 0 4 1 0 1 0 0 2 Alive CONSERVATIVE 9 ALCOHOL + – – – –
23 RAJAM 39206 56 MALE 3 0 0 0 0 2 0 1 0 0 0 0 1 0 7 0 1 1 0 0 2 ALIVE CONSERVATIVE 8 ALCOHOL + – – – –
24 PUSHPAVALLI 39216 45 FEMALE 0 0 0 0 0 0 0 2 2 0 0 0 1 0 5 0 1 0 0 0 1 Alive CONSERVATIVE 6 GSD - + – – –
24 MARISELVAM 42570 24 MALE 0 0 0 1 0 0 2 2 2 0 0 0 2 0 9 0 1 1 0 0 2 Alive CONSERVATIVE 7 IDIOPATHIC + – – – –
26 MOHAN 37469 50 MALE 2 0 0 0 0 0 0 1 2 0 0 0 1 0 6 0 1 1 0 0 2 ALIVE CONSERVATIVE 5 ALCOHOL + – – – –
27 ARUMUGAM 37419 58 MALE 3 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 1 Alive CONSERVATIVE 4 ALCOHOL + – + – –
28 MUNUSAMY 49947 42 MALE 0 0 0 1 0 2 2 1 2 2 0 0 2 0 12 0 1 1 0 1 3 Alive + CONSERVATIVE NECROSIS 18 ALCOHOL + + + – –
29 PRAKASH 50684 25 MALE 0 0 0 1 1 2 2 1 2 0 0 0 2 0 11 0 1 1 0 0 2 Alive CONSERVATIVE 8 GSD + – – – –
30 ARULDAS 38435 60 MALE 3 0 0 0 0 0 0 0 0 1 0 0 2 5 11 0 1 1 0 0 2 Alive CONSERVATIVE 10 ALCOHOL + + – + –
31 MALLESWARI 42262 24 FEMALE 0 0 1 1 0 0 1 0 0 0 0 0 0 0 3 0 0 1 0 0 1 Alive CONSERVATIVE 6 GSD + – + – –
32 WILSON 40677 39 MALE 0 0 1 1 0 0 2 1 0 0 0 0 1 0 6 0 1 1 0 0 2 Alive CONSERVATIVE 7 ALCOHOL + – – – –
33 SRINIVASAN 42845 30 MALE 0 0 0 0 0 0 0 2 0 0 0 0 1 0 3 0 1 0 0 0 1 Alive CONSERVATIVE 6 IDIOPATHIC + – – – –
34 RAMESH 42942 38 MALE 0 0 1 0 0 0 0 0 0 2 0 0 1 0 4 0 1 0 0 0 1 Alive CONSERVATIVE 6 GSD + – – – –
35 SYED IBRAHIM 42947 32 MALE 0 0 0 1 0 0 0 0 0 0 2 0 1 0 4 0 1 1 0 0 2 Alive CONSERVATIVE 8 ALCOHOL + – + – –
36 VIJAYAKUMAR 34459 40 MALE 0 0 1 1 0 0 0 0 2 0 0 0 1 0 5 0 1 1 0 0 2 ALIVE CONSERVATIVE 5 ALCOHOL + – – – –
37 ELUMALAI 34520 47 MALE 2 1 2 1 1 2 2 1 0 2 2 1 2 5 24 1 1 1 0 1 4 Alive + CONSERVATIVE ARDS 19 ALCOHOL + + + – +
38 MANIMEGALAI 34781 49 FEMALE 2 1 0 0 0 0 0 0 2 2 0 0 1 0 6 0 1 1 0 0 2 Alive CONSERVATIVE 9DRUG INDUCED + – – – –
39 KATHIRESAN 33291 42 MALE 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 0 1 2 Alive CONSERVATIVE 9 IDIOPATHIC + – – – –
40 RAJU 33413 40 MALE 0 0 2 1 0 0 0 0 2 0 0 0 1 0 6 0 1 1 0 0 2 Alive CONSERVATIVE 9 IDIOPATHIC + – – – –
41 GEETHA 30611 42 FEMALE 0 0 0 1 0 0 0 0 2 0 0 1 2 0 6 0 1 1 0 0 2 Alive CONSERVATIVE 19 GSD + – – – –
42 JAYARAMAN 33444 27 MALE 0 1 2 3 1 2 2 1 2 4 2 0 2 5 27 1 1 1 0 1 4 ALIVE + + CONSERVATIVE ARF 22 ALCOHOL + + + + +
43 NAGARAJAN 32075 57 MALE 3 0 1 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 1 Alive CONSERVATIVE 6HYPERTRIGLYCERIDEMIA+ – – – –
44 PALANI 32520 32 MALE 0 1 2 1 0 0 0 0 2 2 0 0 1 0 9 0 1 1 0 0 2 Alive CONSERVATIVE 11 ALCOHOL + – – – –
45 BASKAR 28928 48 MALE 2 1 2 1 0 0 0 0 2 0 0 0 0 0 8 0 0 1 0 0 1 Alive CONSERVATIVE 7 IDIOPATHIC + – + – –
46 DHINAKARAN 30619 22 MALE 0 1 2 1 0 2 0 0 2 0 0 0 0 0 8 1 0 0 0 0 1 ALIVE CONSERVATIVE 8 IDIOPATHIC + – – – +
47 NAGABOOSANAM28937 38 MALE 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 2 Alive CONSERVATIVE 12 GSD + + – – –
48 AYYAPPAN 29188 27 MALE 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 Alive CONSERVATIVE 10 ALCOHOL + – – – –
49 SRINIVASAN 29136 34 MALE 0 0 2 1 0 0 0 0 2 0 2 1 0 0 8 0 0 1 0 1 2 Alive CONSERVATIVE 10 IDIOPATHIC + – – – –
50 PREMKUMAR 26628 29 MALE 0 0 2 1 0 0 0 0 2 0 0 0 0 0 5 1 0 1 0 0 2 Alive CONSERVATIVE 14 GSD + – – + –
51 VINCENT 26849 28 MALE 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 Alive CONSERVATIVE 4 IDIOPATHIC + – – – –
52 SIVARANJANI 26682 60 FEMALE 3 0 1 1 1 0 0 0 0 2 0 0 1 5 14 0 0 1 0 1 2 Alive CONSERVATIVE 28HYPERTRIGLYCERIDEMIA+ + + – +
53 KUMAR 25379 46 MALE 2 1 0 1 0 0 0 0 0 0 0 0 0 0 4 0 0 1 0 0 1 Alive CONSERVATIVE 6 IDIOPATHIC + – – – –
54 BABU 25328 30 MALE 0 0 0 1 0 0 0 0 2 0 2 1 1 0 7 0 1 0 0 0 1 Alive CONSERVATIVE 8 GSD + – – – –
55 VIJAYAKUMAR 24611 32 MALE 0 1 2 1 0 0 0 0 2 2 0 0 1 0 9 0 1 1 0 0 2 Alive CONSERVATIVE 12 ALCOHOL + – – + –
56 RAMAMOORTHY 24700 48 MALE 2 1 2 1 0 0 0 0 2 2 0 0 1 0 11 1 1 1 0 0 3 Alive + + CONSERVATIVE
p.NEC 
UGIB 19 GSD + + – – +
57 SELVAKUMAR 22840 30 MALE 0 1 2 1 0 1 0 0 0 2 0 0 2 0 9 0 1 1 0 0 2 Alive CONSERVATIVE 15 IDIOPATHIC + – – – +
58 SUBRAMANI 22619 56 MALE 0 0 2 1 0 0 0 0 2 1 0 1 1 0 8 1 1 1 0 1 4 Death + + SEPSIS 1 ALCOHOL + + + + +
59 GOVINDHAMMAL 40173 27 FEMALE 0 1 1 1 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 1 Alive CONSERVATIVE 6DRUG INDUCED + – + – –
60 RAJENDRAN 22757 50 MALE 2 1 2 0 0 0 0 0 2 2 0 0 2 5 16 0 1 1 0 0 2 Alive CONSERVATIVE 21 ALCOHOL + + – – –
61 ANANDHAN 21681 38 MALE 0 0 0 0 0 0 1 0 0 0 1 0 0 0 2 0 0 0 0 0 0 Alive CONSERVATIVE 5 IDIOPATHIC + – – – –
62 RAMALINGAM 21240 45 MALE 2 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 1 1 Alive CONSERVATIVE 7 IDIOPATHIC + – – – –
63 JAYAKUMAR 49951 80 MALE 6 1 1 1 0 2 2 1 2 2 1 1 4 5 29 1 1 1 1 1 5 DEATH +
MODS/
SEPSIS 1 ALCOHOL + + + + +
64 VASUDEVAN 7827 48 MALE 2 0 2 1 0 0 0 0 2 0 0 0 0 0 7 0 0 1 0 0 1 Alive CONSERVATIVE 8 GSD + – – – –
65 MUNUSAMY 34601 60 MALE 3 0 2 1 0 0 2 1 0 0 0 0 2 5 16 0 1 0 1 0 2 Alive CONSERVATIVE 19 ALCOHOL + – – – +
66 SHANMUGAM 35947 47 MALE 2 0 0 0 0 0 2 2 2 3 0 0 2 5 18 0 1 1 0 0 2 Alive CONSERVATIVE 24 GSD + – + + –
67 UDAYAKUMAR 34982 34 MALE 0 0 0 1 0 0 0 0 0 0 0 0 0 5 6 0 0 0 0 1 1 Alive CONSERVATIVE 10 IDIOPATHIC + – – – –
68 ESWARI 17445 37 FEMALE 0 1 2 1 0 0 0 0 2 0 0 1 2 0 9 1 1 1 0 0 3 ALIVE + + SURGERY ABSCESS 23 TRAUMA + + + – +
69 KUMAR 17447 24 MALE 0 0 2 1 0 2 0 0 2 2 0 1 2 0 12 1 1 0 0 0 2 ALIVE CONSERVATIVE 11 GSD + – – – –
70 BALASUNDARAM 28542 58 MALE 2 0 2 1 0 0 0 1 0 1 0 0 1 0 8 1 1 1 0 1 4 DEATH + MODS/DIC 2 ALCOHOL + + + + +
71 NANDHA 4E+05 55 MALE 3 1 2 1 0 2 0 0 2 0 0 1 3 0 15 0 1 1 0 1 3 Alive + SURGERY ABSCESS 32 TRAUMA + – + + –
72 VASANTH 45186 23 MALE 0 1 2 1 0 2 0 1 2 0 0 0 0 0 9 0 0 1 0 0 1 Alive CONSERVATIVE 7 IDIOPATHIC + – – – –
73 VEERAIAH 38112 42 MALE 0 0 0 0 0 0 0 0 2 0 2 1 0 0 5 0 0 0 0 0 0 Alive CONSERVATIVE 6 IDIOPATHIC + – – – –
74 LOGANATHAN 43336 50 MALE 2 1 2 1 0 0 0 1 2 0 0 0 0 0 9 0 0 1 0 1 2 ALIVE CONSERVATIVE 8HYPERTRIGLYCERIDEMIA+ – – – –
75 AMSA 2461 52 FEMALE 2 1 2 1 0 0 0 0 2 2 0 0 1 0 13 0 1 1 0 0 2 ALIVE + CONSERVATIVE p.NEC 21 GSD + – + – –
76 RAGAVARAJ 3382 36 MALE 0 0 2 1 0 0 0 0 0 0 0 1 5 0 9 0 0 1 0 0 1 Alive CONSERVATIVE 9 ALCOHOL + – – – –
77 SENGOOTUVAN 33501 45 MALE 2 1 2 1 0 0 0 0 2 0 0 0 0 0 8 0 1 0 0 1 2 Alive CONSERVATIVE ARF 29 GSD + + + + +
78KRISHNAMOORTHY51474 45 MALE 2 0 2 1 1 0 0 1 2 2 2 0 2 5 19 0 1 1 0 0 2 Alive CONSERVATIVE 26 ALCOHOL + + – + –
79 ANANDHAN 26918 47 MALE 2 0 0 0 0 0 0 0 0 2 0 0 0 0 4 1 0 0 0 0 1 Alive CONSERVATIVE 6 ALCOHOL + + + – -
80 PILLAIYARSAMY 37807 49 MALE 2 0 2 1 0 0 0 0 2 2 0 0 2 0 11 0 1 1 0 0 2 Alive + CONSERVATIVE PVT 20 ALCOHOL + – + – –
81 ARIVAZHAGAN 32076 46 MALE 2 0 2 1 0 0 0 0 0 0 0 0 0 0 5 0 0 1 0 0 1 Alive CONSERVATIVE 6 GSD + – – - –
82 SURESH 24123 24 MALE 0 1 2 1 0 0 0 1 2 0 0 2 0 0 9 0 0 1 0 0 1 Alive CONSERVATIVE 9 IDIOPATHIC + – + – –
83NAGESWARA RAO64734 25 MALE 0 0 0 0 0 0 0 0 2 0 2 1 0 0 5 1 0 1 0 0 2 Alive + CONSERVATIVE 11 GSD + – – - –
84 ARUN 31829 45 MALE 2 0 0 1 0 0 0 0 2 2 0 0 1 0 8 0 1 1 0 0 2 Alive CONSERVATIVE 12 ALCOHOL + – – – –
85 BAGIYANATHAN 28043 26 MALE 0 0 0 1 0 0 0 0 2 0 0 0 0 0 3 0 0 1 0 0 1 Alive CONSERVATIVE 7 ALCOHOL + – – – –
86 ABDULHAMEED 28086 72 MALE 5 0 0 0 1 0 0 0 2 0 0 0 10 5 13 1 1 0 0 0 2 Alive CONSERVATIVE 18 ALCOHOL + – + – –
87 GANI 29630 45 MALE 2 1 0 1 0 0 0 0 2 0 0 0 0 0 6 0 0 0 0 0 0 Alive CONSERVATIVE 6 IDIOPATHIC + – – – –
88 SIVARAMAN 30475 50 MALE 2 0 2 1 0 0 0 1 0 0 0 0 0 0 6 1 0 1 0 0 2 Alive CONSERVATIVE 9 GSD + – – – –
89 NASEER HUSSAIN29624 45 MALE 2 0 0 0 0 0 0 0 2 0 0 0 0 0 4 0 0 0 0 0 0 Alive CONSERVATIVE 7 IDIOPATHIC – – – – –
90 RAJENDRAN 34711 45 MALE 2 0 2 1 0 0 0 0 0 0 0 0 0 0 5 0 0 1 0 0 1 Alive CONSERVATIVE 6 ALCOHOL – – – – –
91 RANGARAJ 35579 40 MALE 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 Alive CONSERVATIVE 8 ALCOHOL + – – – –
92 MURUGAMMAL 36497 30 FEMALE 0 1 2 1 0 0 0 0 2 0 0 0 1 5 12 0 1 1 0 0 2 ALIVE + CONSERVATIVE HYPOCAL 19 ALCOHOL + – + – –
93 PALANI 36509 37 MALE 0 1 2 1 0 0 0 0 0 0 2 1 0 0 7 0 0 1 0 0 1 Alive CONSERVATIVE 9 GSD + – – - –
94 DILLY 35639 60 MALE 3 0 2 1 0 0 0 1 2 2 0 0 2 5 18 1 1 1 0 1 4 Alive + + CONSERVATIVE
ARF/
MET.EN 26 ALCOHOL + + + – –
95 MABU BASHA 35685 45 MALE 2 0 0 1 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 1 Alive CONSERVATIVE 9 IDIOPATHIC – – – – –
96 EKAMBARAM 38263 50 MALE 2 1 2 0 0 0 0 0 0 0 0 0 1 0 6 1 1 0 0 0 2 Alive CONSERVATIVE 11 ALCOHOL + + + – –
97 KAMALESWARAN51612 32 MALE 0 1 2 3 0 0 0 0 2 2 0 0 1 0 10 1 1 0 0 0 2 ALIVE + CONSERVATIVE ARF 21 GSD + – – + –
98 RADHAKRISHNAN51658 55 MALE 3 1 2 1 0 0 0 0 2 2 0 1 2 5 19 0 1 1 0 1 3 Alive + SURGERY
p.CYST
/p.NEC 19 ALCOHOL + – + - –
99 RAJESH 33762 45 MALE 2 0 2 1 0 0 0 0 2 0 1 1 1 0 10 0 1 1 0 0 2 Alive + CONSERVATIVE 20 ALCOHOL + – – – –
100 JEEVA 34448 41 MALE 0 0 2 1 0 0 0 0 2 0 0 0 0 0 5 0 0 1 0 0 1 Alive CONSERVATIVE 10 ALCOHOL – – – – –
